| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Mar―30 |
RBD-depleted SARS-CoV-2 spike generates protective immunity in cynomolgus macaques |
Hélène Letscher, Delphine Guilligay, Gregory Effantin, Axelle Amen, Guidenn Sulbaran, Judith A. Burger, Laetitia Bossevot, Laura Junges, Marco Leonec, Julie Morin, Matthieu Van Tilbeurgh, Cécile Hérate, Anne-Sophie Gallouët, Francis Relouzat, Sylvie van der Werf, Mariangela Cavarelli, Nathalie Dereuddre-Bosquet, Marit J. van Gils, Rogier W. Sanders, Pascal Poignard, Roger Le Grand, Winfried Weissenhorn |
| 2 |
[GO] |
2025―Mar―29 |
Modeling the impact of early vaccination in an influenza pandemic in the United States |
Van Hung Nguyen, Pascal Crépey, B. Adam Williams, Verna L. Welch, Jean Marie Pivette, Charles H. Jones, Jane M. True |
| 3 |
[GO] |
2025―Mar―29 |
Author Correction: Changes in vaccine attitudes and recommendations among US Healthcare Personnel during the COVID-19 pandemic |
Matthew Z. Dudley, Holly B. Schuh, Amanda Forr, Jana Shaw, Daniel A. Salmon |
| 4 |
[GO] |
2025―Mar―17 |
A randomized phase I trial of intranasal SARS-CoV-2 vaccine dNS1-RBD in children aged 3-17 years |
Kai Chu, Jiali Quan, Xiaohui Liu, Qi Chen, Xia Zang, Hanmin Jiang, Donglin Liu, Xiafei Chu, Chunlan Zhuang, Jinle Han, Xiangzhong Ye, Hongxing Pan, Shoujie Huang, Ting Wu, Jun Zhang, Ningshao Xia |
| 5 |
[GO] |
2025―Mar―17 |
Differential efficacy of first licensed western vaccines protecting without immunopathogenesis Wuhan-1-challenged hamsters from severe COVID-19 |
Aileen Ebenig, Mona V. Lange, Michelle Gellhorn Serra, Alexandra Kupke, Roland Plesker, Bingqian Qu, Richard J. P. Brown, Thorsten J. Maier, Michael D. Mühlebach |
| 6 |
[GO] |
2025―Mar―01 |
Cellular immune breadth of an Omicron-specific, self-amplifying monovalent mRNA vaccine booster for COVID-19 |
Durgesh Kumar, Kshitij Gaikwad, Rushank Gunnale, Sandeep Vishwakarma, Shalu Shukla, Shalini Srivastava, Janhavi Gopal, Bhalchandra Vaidya, Amit Saraf, Rohan Gurjar, Swarnendu Kaviraj, Ajay Singh, Arjun Raghuwanshi, Praveen Agarwal, Laxman Savergave, Sanjay Singh |
| 7 |
[GO] |
2025―Feb―27 |
SARS-CoV-2 infection primes cross-protective respiratory IgA in a MyD88- and MAVS-dependent manner |
Moe Kobayashi, Nene Kobayashi, Kyoka Deguchi, Seira Omori, Takeshi Ichinohe |
| 8 |
[GO] |
2025―Feb―13 |
Combined immunization with SARS-CoV-2 spike and SARS-CoV nucleocapsid protects K18-hACE2 mice but increases lung pathology |
Jaekwan Kim, Alla Kachko, Prabhuanand Selvaraj, David Rotstein, Charles Brandon Stauft, Naveen Rajasagi, Yangqing Zhao, Tony Wang, Marian Major |
| 9 |
[GO] |
2025―Jan―30 |
Identifying falsified COVID-19 vaccines by analysing vaccine vial label and excipient profiles using MALDI-ToF mass spectrometry |
Benediktus Yohan Arman, Rebecca Clarke, Tehmina Bharucha, Laura Gomez Fernandez, John Walsby-Tickle, Michael Deats, Sara Mosca, Qianqi Lin, Sneha Banerjee, Shrikrishna R. Chunekar, Kundan D. Patil, Sunil Gairola, Susanna Dunachie, Hamid A. Merchant, Robert Stokes, Rutendo Kuwana, Alexandrine Maes, Jean-Philippe Charrier, Fay Probert, Céline Caillet, Pavel Matousek, James McCullagh, Paul N. Newton, Nicole Zitzmann, Bevin Gangadharan |
| 10 |
[GO] |
2025―Jan―13 |
mRNA vaccines with RBD mutations have broad-spectrum activity against SARS-CoV-2 variants in mice |
Xiaoming Liang, Yuxia Yuan, Junbin Wang, Cong Tang, Yun Yang, Yanan Zhou, Hao Yang, Qing Huang, Wenhai Yu, Haixuan Wang, Yuhuan Yan, Dongdong Lin, Yanwen Li, Xuena Du, Longhai Yuan, Wenqi Quan, Daoju Wu, Shuaiyao Lu |
| 11 |
[GO] |
2025―Jan―10 |
A bivalent COVID-19 mRNA vaccine elicited broad immune responses and protection against Omicron subvariants infection |
Jun Liu, Li Wang, Alexandra Kurtesi, Patrick Budylowski, Kyle G. Potts, Haritha Menon, Yilin Tan, Philip Samaan, Xinan Liu, Yisen Wang, Queenie Hu, Reuben Samson, Freda Qi, Danyel Evseev, Cini John, Kristofor K. Ellestad, Yue Fan, Frans Budiman, Ellaine Riczly Tohan, Suji Udayakumar, Jennifer Yang, Eric G. Marcusson, Anne-Claude Gingras, Douglas J. Mahoney, Mario A. Ostrowski, Natalia Martin-Orozco |
| 12 |
[GO] |
2024―Dec―19 |
Co-immunization with spike and nucleocapsid based DNA vaccines for long-term protective immunity against SARS-CoV-2 Omicron |
Paolla Beatriz Almeida Pinto, Julia Timis, Kantinan Chuensirikulchai, Qin Hui Li, Hsueh Han Lu, Erin Maule, Michael Nguyen, Rúbens Prince dos Santos Alves, Shailendra Kumar Verma, Fernanda Ana-Sosa-Batiz, Kristen Valentine, Sara Landeras-Bueno, Kenneth Kim, Kathryn Hastie, Erica Ollmann Saphire, Ada Alves, Annie Elong Ngono, Sujan Shresta |
| 13 |
[GO] |
2024―Nov―29 |
Mass cytometry reveals cellular correlates of immune response heterogeneity to SARS-CoV-2 vaccination in the elderly |
Ratnadeep Mukherjee, Linn Margrethe Eggesbø, Asia-Sophia Wolf, Ingrid Fadum Kjønstad, Guri Solum, Anthony Ravussin, Sabin Bhandari, Anna Hayman Robertson, Per Magnus, Lill Trogstad, Anja Bråthen Kristoffersen, Unni Cecilie Nygaard, Siri Mjaaland |
| 14 |
[GO] |
2024―Nov―25 |
Author Correction: Reply to: mRNA COVID-19 vaccinations are not associated with RVO development 21 days and 12 weeks after vaccination |
Jing-Xing Li, Yu-Hsun Wang, Henry Bair, Shu-Bai Hsu, Connie Chen, James Cheng-Chung Wei, Chun-Ju Lin |
| 15 |
[GO] |
2024―Nov―23 |
A randomized trial comparing safety, immunogenicity and efficacy of self-amplifying mRNA and adenovirus-vector COVID-19 vaccines |
Nhan Thi Ho, Steve G. Hughes, Rose Sekulovich, Van Thanh Ta, Thuong Vu Nguyen, Anh Thi Van Pham, Quang Chan Luong, Ly Thi Le Tran, Anh Thi Van Luu, Anh Ngoc Nguyen, Ha Thai Pham, Van Thu Nguyen, Dina Berdieva, Roberto Bugarini, Xuexuan Liu, Carole Verhoeven, Igor Smolenov, Xuan-Hung Nguyen |
| 16 |
[GO] |
2024―Nov―21 |
Effect of XBB.1.5-adapted booster vaccination on the imprinting of SARS-CoV-2 immunity |
Jernej Pušnik, Werner O. Monzon-Posadas, Emmanuil Osypchuk, Aleksandra Elzbieta Dubiel, Maximilian Baum, Paulina Fehring, Antonia Büning, Tobias Klant, Hendrik Streeck |
| 17 |
[GO] |
2024―Nov―20 |
Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine |
Kayvon Modjarrad, Ye Che, Wei Chen, Huixian Wu, Carla I. Cadima, Alexander Muik, Mohan S. Maddur, Kristin R. Tompkins, Lyndsey T. Martinez, Hui Cai, Minah Ramos, Sonia Mensah, Brittney Cumbia, Larissa Falcao, Andrew P. McKeen, Jeanne S. Chang, Kimberly F. Fennell, Kevin W. Huynh, Thomas J. McLellan, Parag V. Sahasrabudhe, Wei Chen, Michael Cerswell, Miguel A. Garcia, Shilong Li, Rahul Sharma, Weiqiang Li, Kristianne P. Dizon, Stacy Duarte, Frank Gillett, Rachel Smith, Deanne M. Illenberger, Kari Sweeney Efferen, Annette B. Vogel, Annaliesa S. Anderson, Uğur Şahin, Kena A. Swanson |
| 18 |
[GO] |
2024―Nov―18 |
Obesity does not influence SARS-CoV-2 humoral vaccine immunogenicity |
Mathieu D’Souza, Alexa Keeshan, Christopher A. Gravel, Marc-André Langlois, Curtis L. Cooper |
| 19 |
[GO] |
2024―Nov―11 |
Neutralization of SARS-CoV-2 KP.1, KP.1.1, KP.2 and KP.3 by human and murine sera |
Kun Xu, Yaling An, Xueyuan Liu, Haitang Xie, Dedong Li, Ting Yang, Minrun Duan, Yuanzhuo Wang, Xin Zhao, Lianpai Dai, George F. Gao |
| 20 |
[GO] |
2024―Oct―31 |
Safety, efficacy and immunogenicity of aerosolized Ad5-nCoV COVID-19 vaccine in a non-inferiority randomized controlled trial |
Chun K. Chew, Ruijie Wang, Sunita Bavanandan, Norliza Zainudin, Xiaoyuan Zhao, Sumeyya Ahmed, Damenthi Nair, Lihua Hou, Rosnawati Yahya, Shereen S. Ch’ng, Lai H. Pang, Azrini Abdul Aziz, Haitao Huang, Reena Rajasuriar, Shipo Wu, Zhe Zhang, Xuewen Wang, Geok Y. Chun, Aisyah Mohd Norzi, Kit Y. Cheah, Yi L. Lee, Wan H. Wan Mohamad, Mohamad R. Mohd Din, Wan M. R. Wan Ahmad Kamil, Min H. Tan, Xiaoyu Xu, Lina Wang, Meixu Yan, Yusi Liu, Voon K. Chin, Jau S. Teo, Teck O. Lim, Tao Zhu, Jinbo Gou, Sharon S. M. Ng |
| 21 |
[GO] |
2024―Oct―30 |
High protection and transmission-blocking immunity elicited by single-cycle SARS-CoV-2 vaccine in hamsters |
Martin Joseph Lett, Fabian Otte, David Hauser, Jacob Schön, Enja Tatjana Kipfer, Donata Hoffmann, Nico J. Halwe, Angele Breithaupt, Lorenz Ulrich, Tobias Britzke, Jana Kochmann, Björn Corleis, Yuepeng Zhang, Lorena Urda, Vladimir Cmiljanovic, Christopher Lang, Martin Beer, Christian Mittelholzer, Thomas Klimkait |
| 22 |
[GO] |
2024―Oct―28 |
Reply to: mRNA COVID-19 vaccinations are not associated with RVO development 21 days and 12 weeks after vaccination |
Jing-Xing Li, Yu-Hsun Wang, Henry Bair, Shu-Bai Hsu, Connie Chen, James Cheng-Chung Wei, Chun-Ju Lin |
| 23 |
[GO] |
2024―Oct―28 |
Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity |
Alberto Moreno, Kelly Manning, Maryam I. Azeem, Ajay K. Nooka, Madison Ellis, Renee Julia Manalo, Jeffrey M. Switchenko, Bushra Wali, Jonathan L. Kaufman, Craig C. Hofmeister, Nisha S. Joseph, Sagar Lonial, Kavita M. Dhodapkar, Madhav V. Dhodapkar, Mehul S. Suthar |
| 24 |
[GO] |
2024―Oct―28 |
mRNA COVID-19 vaccinations are not associated with RVO development 21 days and 12 weeks after vaccination |
Jacqueline K. Shaia, Priya Shukla, Lee Jampol, Rishi P. Singh |
| 25 |
[GO] |
2024―Oct―22 |
Broad cross neutralizing antibodies against sarbecoviruses generated by SARS-CoV-2 infection and vaccination in humans |
Yabin Hu, Qian Wu, Fangfang Chang, Jing Yang, Xiaoyue Zhang, Qijie Wang, Jun Chen, Shishan Teng, Yongchen Liu, Xingyu Zheng, You Wang, Rui Lu, Dong Pan, Zhanpeng Liu, Fen Liu, Tianyi Xie, Chanfeng Wu, Yinggen Tang, Fei Tang, Jun Qian, Hongying Chen, Wenpei Liu, Yi-Ping Li, Xiaowang Qu |
| 26 |
[GO] |
2024―Oct―16 |
A multiantigenic Orf virus-based vaccine efficiently protects hamsters and nonhuman primates against SARS-CoV-2 |
Alena Reguzova, Melanie Müller, Felix Pagallies, Dominique Burri, Ferdinand Salomon, Hanns-Joachim Rziha, Zsofia Bittner-Schrader, Babs E. Verstrepen, Kinga P. Böszörményi, Ernst J. Verschoor, Ingo Gerhauser, Knut Elbers, Meral Esen, Alessandro Manenti, Martina Monti, Hans-Georg Rammensee, Madiha Derouazi, Markus W. Löffler, Ralf Amann |
| 27 |
[GO] |
2024―Oct―09 |
Vaccine responses and hybrid immunity in people living with HIV after SARS-CoV-2 breakthrough infections |
Amin Alirezaylavasani, Linda Gail Skeie, Ingrid Marie Egner, Adity Chopra, Tuva Børresdatter Dahl, Christian Prebensen, John Torgils Vaage, Bente Halvorsen, Fridtjof Lund-Johansen, Kristian Tonby, Dag Henrik Reikvam, Birgitte Stiksrud, Jan Cato Holter, Anne Ma Dyrhol-Riise, Ludvig A. Munthe, Hassen Kared |
| 28 |
[GO] |
2024―Oct―08 |
Potent neutralization of SARS-CoV-2 variants by RBD nanoparticle and prefusion-stabilized spike immunogens |
Marcos C. Miranda, Elizabeth Kepl, Mary Jane Navarro, Chengbo Chen, Max Johnson, Kaitlin R. Sprouse, Cameron Stewart, Anne Palser, Adian Valdez, Deleah Pettie, Claire Sydeman, Cassandra Ogohara, John C. Kraft, Minh Pham, Michael Murphy, Sam Wrenn, Brooke Fiala, Rashmi Ravichandran, Daniel Ellis, Lauren Carter, Davide Corti, Paul Kellam, Kelly Lee, Alexandra C. Walls, David Veesler, Neil P. King |
| 29 |
[GO] |
2024―Sep―28 |
Development of T follicular helper cell-independent nanoparticle vaccines for SARS-CoV-2 or HIV-1 by targeting ICOSL |
Yongli Zhang, Achun Chen, Daiying Li, Quyu Yuan, Airu Zhu, Jieyi Deng, Yalin Wang, Jie Liu, Chaofeng Liang, Wenjie Li, Qiannan Fang, Jiatong Xie, Xiantao Zhang, Xu Zhang, Yiwen Zhang, Ran Chen, Ting Pan, Hui Zhang, Xin He |
| 30 |
[GO] |
2024―Sep―19 |
Author Correction: The direct effect of SARS-CoV-2 virus vaccination on human ovarian granulosa cells explains menstrual irregularities |
Hadas Bar-Joseph, Yael Raz, Anat Eldar-Boock, Nadav Michaan, Yoel Angel, Esther Saiag, Luba Nemerovsky, Ido Ben-Ami, Ruth Shalgi, Dan Grisaru |
| 31 |
[GO] |
2024―Sep―18 |
Low-frequency CD8+ T cells induced by SIGN-R1+ macrophage-targeted vaccine confer SARS-CoV-2 clearance in mice |
Daisuke Muraoka, Meng Ling Moi, Osamu Muto, Takaaki Nakatsukasa, Situo Deng, Chieko Takashima, Rui Yamaguchi, Shin-ichi Sawada, Haruka Hayakawa, Thi Thanh Ngan Nguyen, Yasunari Haseda, Takatoshi Soga, Hirokazu Matsushita, Hiroaki Ikeda, Kazunari Akiyoshi, Naozumi Harada |
| 32 |
[GO] |
2024―Sep―14 |
Understanding the rationales and information environments for early, late, and nonadopters of the COVID-19 vaccine |
Lisa Singh, Le Bao, Leticia Bode, Ceren Budak, Josh Pasek, Trivellore Raghunathan, Michael Traugott, Yanchen Wang, Nathan Wycoff |
| 33 |
[GO] |
2024―Sep―13 |
Risk benefit analysis to evaluate risk of thromboembolic events after mRNA COVID-19 vaccination and COVID-19 |
Huong N. Q. Tran, Malcolm Risk, Girish B. Nair, Lili Zhao |
| 34 |
[GO] |
2024―Sep―13 |
COVID-19 vaccine refusal is driven by deliberate ignorance and cognitive distortions |
Kamil Fuławka, Ralph Hertwig, Thorsten Pachur |
| 35 |
[GO] |
2024―Sep―09 |
Computationally designed Spike antigens induce neutralising responses against the breadth of SARS-COV-2 variants |
Sneha Vishwanath, George William Carnell, Martina Billmeier, Luis Ohlendorf, Patrick Neckermann, Benedikt Asbach, Charlotte George, Maria Suau Sans, Andrew Chan, Joey Olivier, Angalee Nadesalingam, Sebastian Einhauser, Nigel Temperton, Diego Cantoni, Joe Grove, Ingo Jordan, Volker Sandig, Paul Tonks, Johannes Geiger, Christian Dohmen, Verena Mummert, Anne Rosalind Samuel, Christian Plank, Rebecca Kinsley, Ralf Wagner, Jonathan Luke Heeney |
| 36 |
[GO] |
2024―Sep―04 |
Broad protection and respiratory immunity of dual mRNA vaccination against SARS-CoV-2 variants |
Renee L. Hajnik, Jessica A. Plante, Srinivasa Reddy Bonam, Grace H. Rafael, Yuejin Liang, Nicholas C. Hazell, Jordyn Walker, Rachel A. Reyna, David H. Walker, Mohamad-Gabriel Alameh, Drew Weissman, Scott C. Weaver, Kenneth S. Plante, Haitao Hu |
| 37 |
[GO] |
2024―Aug―27 |
Neutralizing and binding antibody responses to SARS-CoV-2 with hybrid immunity in pregnancy |
Lin Li, Yusuke Matsui, Mary K. Prahl, Arianna G. Cassidy, Yarden Golan, Unurzul Jigmeddagva, Nida Ozarslan, Christine Y. Lin, Sirirak Buarpung, Veronica J. Gonzalez, Megan A. Chidboy, Emilia Basilio, Kara L. Lynch, Dongli Song, Priya Jegatheesan, Daljeet S. Rai, Balaji Govindaswami, Jordan Needens, Monica Rincon, Leslie Myatt, Taha Y. Taha, Mauricio Montano, Melanie Ott, Warner C. Greene, Stephanie L. Gaw |
| 38 |
[GO] |
2024―Aug―14 |
COVID-19 and influenza vaccine uptake among pregnant women in national cohorts of England and Wales |
Xinchun Gu, Utkarsh Agrawal, William Midgley, Stuart Bedston, Sneha N. Anand, Rosalind Goudie, Rachel Byford, Mark Joy, Gavin Jamie, Uy Hoang, Jose M. Ordóñez-Mena, Chris Robertson, F. D. Richard Hobbs, Ashley Akbari, Aziz Sheikh, Simon de Lusignan |
| 39 |
[GO] |
2024―Aug―10 |
Dynamic clade transitions and the influence of vaccination on the spatiotemporal circulation of SARS-CoV-2 variants |
Cecília Artico Banho, Beatriz de Carvalho Marques, Lívia Sacchetto, Ana Karoline Sepedro Lima, Maisa Carla Pereira Parra, Alex Ranieri Jeronimo Lima, Gabriela Ribeiro, Antonio Jorge Martins, Claudia Renata dos Santos Barros, Maria Carolina Elias, Sandra Coccuzzo Sampaio, Svetoslav Nanev Slavov, Evandra Strazza Rodrigues, Elaine Vieira Santos, Dimas Tadeu Covas, Simone Kashima, Ricardo Augusto Brassaloti, Bruna Petry, Luan Gaspar Clemente, Luiz Lehmann Coutinho, Patricia Akemi Assato, Felipe Allan da Silva da Costa, Rejane Maria Tommasini Grotto, Mirele Daiana Poleti, Jessika Cristina Chagas Lesbon, Elisangela Chicaroni Mattos, Heidge Fukumasu, Marta Giovanetti, Luiz Carlos Junior Alcantara, Jayme A. Souza-Neto, Paula Rahal, João Pessoa Araújo, Fernando Rosado Spilki, Benjamin M. Althouse, Nikos Vasilakis, Maurício Lacerda Nogueira |
| 40 |
[GO] |
2024―Aug―03 |
Esoteric beliefs and CAM impact SARS-CoV-2 immunization drivers, uptake and pediatric immunization views in Germany |
Sebastian Jäckle, James K. Timmis |
| 41 |
[GO] |
2024―Jul―25 |
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV |
Gang Wang, Abhishek K. Verma, Juan Shi, Xiaoqing Guan, David K. Meyerholz, Fan Bu, Wei Wen, Bin Liu, Fang Li, Stanley Perlman, Lanying Du |
| 42 |
[GO] |
2024―Jul―22 |
A trivalent protein-based pan-Betacoronavirus vaccine elicits cross-neutralizing antibodies against a panel of coronavirus pseudoviruses |
Syamala Rani Thimmiraju, Rakesh Adhikari, JeAnna R. Redd, Maria Jose Villar, Jungsoon Lee, Zhuyun Liu, Yi-Lin Chen, Suman Sharma, Amandeep Kaur, Nestor L. Uzcategui, Shannon E. Ronca, Wen-Hsiang Chen, Jason T. Kimata, Bin Zhan, Ulrich Strych, Maria Elena Bottazzi, Peter J. Hotez, Jeroen Pollet |
| 43 |
[GO] |
2024―Jul―20 |
A scoping review of global COVID-19 vaccine hesitancy among pregnant persons |
Imaima Casubhoy, Alyssa Kretz, Heang-Lee Tan, Laura A. St Clair, Maclaine Parish, Hana Golding, Susan J. Bersoff-Matcha, Catherine Pilgrim-Grayson, Leah Berhane, Andrew Pekosz, Heba H. Mostafa, Andrea L. Cox, Irina Burd, Sabra L. Klein, Rosemary Morgan |
| 44 |
[GO] |
2024―Jul―16 |
Standardized immunological assays for assessing COVID-19 vaccines by the CEPI-Centralized Laboratory Network |
Ali Azizi, Deborah Ogbeni, Gathoni Kamuyu, Lauren M. Schwartz, Carolyn Clark, Peter Spencer, Valentina Bernasconi |
| 45 |
[GO] |
2024―Jul―16 |
Homologous but not heterologous COVID-19 vaccine booster elicits IgG4+ B-cells and enhanced Omicron subvariant binding |
Gemma E. Hartley, Holly A. Fryer, Paul A. Gill, Irene Boo, Scott J. Bornheimer, P. Mark Hogarth, Heidi E. Drummer, Robyn E. O’Hehir, Emily S. J. Edwards, Menno C. van Zelm |
| 46 |
[GO] |
2024―Jun―28 |
Myocarditis associated with COVID-19 vaccination |
Alessandra Buoninfante, Arno Andeweg, Georgy Genov, Marco Cavaleri |
| 47 |
[GO] |
2024―Jun―26 |
The direct effect of SARS-CoV-2 virus vaccination on human ovarian granulosa cells explains menstrual irregularities |
Hadas Bar-Joseph, Yael Raz, Anat Eldar-Boock, Nadav Michaan, Yoel Angel, Esther Saiag, Luba Nemerovsky, Ido Ben-Ami, Ruth Shalgi, Dan Grisaru |
| 48 |
[GO] |
2024―Jun―20 |
Calcifediol boosts efficacy of ChAdOx1 nCoV-19 vaccine by upregulating genes promoting memory T cell responses |
Himanshu Singh Saroha, Swati Bhat, Liza Das, Pinaki Dutta, Michael F. Holick, Naresh Sachdeva, Raman Kumar Marwaha |
| 49 |
[GO] |
2024―Jun―18 |
Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model |
Ross N. England, Elizabeth M. Drapeau, Mohamad-Gabriel Alameh, Reihaneh Hosseinzadeh, Drew Weissman, Scott E. Hensley |
| 50 |
[GO] |
2024―Jun―14 |
Association between antibody responses post-vaccination and severe COVID-19 outcomes in Scotland |
Calum Macdonald, Norah Palmateer, Andrew McAuley, Laura Lindsay, Taimoor Hasan, Safraj Shahul Hameed, Elliot Hall, Karen Jeffrey, Zoë Grange, Petros Gousias, Sally Mavin, Lisa Jarvis, J. Claire Cameron, Luke Daines, Holly Tibble, Colin R. Simpson, Colin McCowan, Srinivasa Vittal Katikireddi, Igor Rudan, Adeniyi Francis Fagbamigbe, Lewis Ritchie, Ben Swallow, Paul Moss, Chris Robertson, Aziz Sheikh, Josie Murray |
| 51 |
[GO] |
2024―May―28 |
SARS-CoV-2-specific immune responses converge in kidney disease patients and controls with hybrid immunity |
Muriel Aguilar-Bretones, Yvette den Hartog, Laura L. A. van Dijk, S. Reshwan K. Malahe, Marjolein Dieterich, Héctor Tejeda Mora, Yvonne M. Mueller, Marion P. G. Koopmans, Marlies E. J. Reinders, Carla C. Baan, Gijsbert P. van Nierop, Rory D. de Vries, Alferso C. Abrahams, Marije C. Baas, Marc H. Hemmelder, Pim Bouwmans, Marc A. G. J. ten Dam, Lennert Gommers, Aiko P. J. de Vries |
| 52 |
[GO] |
2024―May―23 |
Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges |
Bryce M. Warner, Jacob G. E. Yates, Robert Vendramelli, Thang Truong, Courtney Meilleur, Lily Chan, Alexander Leacy, Phuc H. Pham, Yanlong Pei, Leonardo Susta, Sarah K. Wootton, Darwyn Kobasa |
| 53 |
[GO] |
2024―May―22 |
Influence of individuals’ determinants including vaccine type on cellular and humoral responses to SARS-CoV-2 vaccination |
Emma S. Chambers, Weigang Cai, Giulia Vivaldi, David A. Jolliffe, Natalia Perdek, Wenhao Li, Sian E. Faustini, Joseph M. Gibbons, Corinna Pade, Alex G. Richter, Anna K. Coussens, Adrian R. Martineau |
| 54 |
[GO] |
2024―May―18 |
Author Correction: Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium |
Laura Marcos-Villar, Beatriz Perdiguero, Shubaash Anthiya, Mireya L. Borrajo, Gustavo Lou, Lorenzo Franceschini, Ignasi Esteban, Pedro J. Sánchez-Cordón, Carmen Zamora, Carlos Óscar S. Sorzano, Luis Jordá, Laia Codó, Josep L. Gelpí, Marta Sisteré-Oró, Andreas Meyerhans, Kris Thielemans, Francisco Martínez-Jiménez, Núria López-Bigas, Felipe García, María J. Alonso, Montserrat Plana, Mariano Esteban, Carmen Elena Gómez |
| 55 |
[GO] |
2024―May―18 |
Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera |
Annika Rössler, Antonia Netzl, Ludwig Knabl, Samuel H. Wilks, Barbara Mühlemann, Sina Türeli, Anna Mykytyn, Dorothee von Laer, Bart L. Haagmans, Derek J. Smith, Janine Kimpel |
| 56 |
[GO] |
2024―Apr―08 |
Recovery from antibody-mediated biliary ductopenia and multiorgan inflammation after COVID-19 vaccination |
Alan Chang, Yung-Ming Jeng, Cheng-Maw Ho, Po-Huang Lee |
| 57 |
[GO] |
2024―Apr―05 |
COVID-19 vaccination induces distinct T-cell responses in pediatric solid organ transplant recipients and immunocompetent children |
Katerina Roznik, Jiashu Xue, Georgia Stavrakis, T. Scott Johnston, Divya Kalluri, Rivka Ohsie, Caroline X. Qin, John McAteer, Dorry L. Segev, Douglas Mogul, William A. Werbel, Andrew H. Karaba, Elizabeth A. Thompson, Andrea L. Cox |
| 58 |
[GO] |
2024―Mar―21 |
An intranasal combination vaccine induces systemic and mucosal immunity against COVID-19 and influenza |
Man Xing, Gaowei Hu, Xiang Wang, Yihan Wang, Furong He, Weiqian Dai, Xinyu Wang, Yixin Niu, Jiaojiao Liu, Hui Liu, Xiaoyan Zhang, Jianqing Xu, Qiliang Cai, Dongming Zhou |
| 59 |
[GO] |
2024―Mar―20 |
Expansion of memory Vδ2 T cells following SARS-CoV-2 vaccination revealed by temporal single-cell transcriptomics |
Sara Terzoli, Paolo Marzano, Valentina Cazzetta, Rocco Piazza, Inga Sandrock, Sarina Ravens, Likai Tan, Immo Prinz, Simone Balin, Michela Calvi, Anna Carletti, Assunta Cancellara, Nicolò Coianiz, Sara Franzese, Alessandro Frigo, Antonio Voza, Francesca Calcaterra, Clara Di Vito, Silvia Della Bella, Joanna Mikulak, Domenico Mavilio |
| 60 |
[GO] |
2024―Mar―06 |
Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium |
Laura Marcos-Villar, Beatriz Perdiguero, Shubaash Anthiya, Mireya L. Borrajo, Gustavo Lou, Lorenzo Franceschini, Ignasi Esteban, Pedro J. Sánchez-Cordón, Carmen Zamora, Carlos Óscar S. Sorzano, Luis Jordá, Laia Codó, Josep L. Gelpí, Marta Sisteré-Oró, Andreas Meyerhans, Kris Thielemans, Francisco Martínez-Jiménez, Nuria López-Vigas, Felipe García, María J. Alonso, Montserrat Plana, Mariano Esteban, Carmen Elena Gómez |
| 61 |
[GO] |
2024―Mar―04 |
A register and questionnaire study of long-term general health symptoms following SARS-CoV-2 vaccination in Denmark |
Elisabeth O’Regan, Ingrid Bech Svalgaard, Anna Irene Vedel Sørensen, Lampros Spiliopoulos, Peter Bager, Nete Munk Nielsen, Jørgen Vinsløv Hansen, Anders Koch, Inger Kristine Meder, Poul Videbech, Steen Ethelberg, Anders Hviid |
| 62 |
[GO] |
2024―Feb―28 |
Changes in vaccine attitudes and recommendations among US Healthcare Personnel during the COVID-19 pandemic |
Matthew Z. Dudley, Holly B. Schuh, Amanda Forr, Jana Shaw, Daniel A. Salmon |
| 63 |
[GO] |
2024―Feb―27 |
Immunisation efficacy of a stabilised SARS-CoV-2 spike glycoprotein in two geriatric animal models |
Carla Usai, Erola Ainsua-Enrich, Victor Urrea Gales, Edwards Pradenas, Cristina Lorca-Oró, Ferran Tarrés-Freixas, Núria Roca, Mónica Pérez, Carlos Ávila-Nieto, María Luisa Rodríguez de la Concepción, Núria Pedreño-Lopez, Julieta Carabelli, Benjamin Trinité, Ester Ballana, Eva Riveira-Muñoz, Nuria Izquierdo-Useros, Bonaventura Clotet, Julià Blanco, Victor Guallar, Guillermo Cantero, Júlia Vergara-Alert, Jorge Carrillo, Joaquim Segalés |
| 64 |
[GO] |
2024―Feb―23 |
Durable cross-protective neutralizing antibody responses elicited by lipid nanoparticle-formulated SARS-CoV-2 mRNA vaccines |
Ki Hyun Bae, Bhuvaneshwari Shunmuganathan, Li Zhang, Andrew Lim, Rashi Gupta, Yanming Wang, Boon Lin Chua, Yang Wang, Yue Gu, Xinlei Qian, Isabelle Siang Ling Tan, Kiren Purushotorman, Paul A. MacAry, Kevin P. White, Yi Yan Yang |
| 65 |
[GO] |
2024―Feb―22 |
No link between type I interferon autoantibody positivity and adverse reactions to COVID-19 vaccines |
Ahmet Yalcinkaya, Marco Cavalli, Axel Cederholm, Maribel Aranda-Guillén, Anish Behere, Hedvig Mildner, Tadepally Lakshmikanth, Laura Gonzalez, Constantin Habimana Mugabo, Anette Johnsson, Olov Ekwall, Olle Kämpe, Sophie Bensing, Petter Brodin, Pär Hallberg, Mia Wadelius, Nils Landegren |
| 66 |
[GO] |
2024―Feb―21 |
Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine |
David G. Alleva, Eline A. Feitsma, Yester F. Janssen, Hendrikus H. Boersma, Thomas M. Lancaster, Thillainaygam Sathiyaseelan, Sylaja Murikipudi, Andrea R. Delpero, Melanie M. Scully, Ramya Ragupathy, Sravya Kotha, Jeffrey R. Haworth, Nishit J. Shah, Vidhya Rao, Shashikant Nagre, Shannon E. Ronca, Freedom M. Green, Stephen A. Shaw, Ari Aminetzah, Schelto Kruijff, Maarten Brom, Gooitzen M. van Dam, Todd C. Zion |
| 67 |
[GO] |
2024―Feb―20 |
Impact of ageing on homologous and human-coronavirus-reactive antibodies after SARS-CoV-2 vaccination or infection |
Fan Zhou, Juha Vahokoski, Siri Øyen, Marianne Sævik, Hanne Høyland, Helene H. Sandnes, Anders Madsen, Karl A. Brokstad, Kristin G. I. Mohn, Camilla Tøndel, Nina Langeland, Rebecca J. Cox |
| 68 |
[GO] |
2024―Feb―05 |
SARS-CoV-2 vaccination may mitigate dysregulation of IL-1/IL-18 and gastrointestinal symptoms of the post-COVID-19 condition |
Claudia Fischer, Edith Willscher, Lisa Paschold, Cornelia Gottschick, Bianca Klee, Sophie Diexer, Lidia Bosurgi, Jochen Dutzmann, Daniel Sedding, Thomas Frese, Matthias Girndt, Jessica I. Hoell, Michael Gekle, Marylyn M. Addo, Julian Schulze zur Wiesch, Rafael Mikolajczyk, Mascha Binder, Christoph Schultheiß |
| 69 |
[GO] |
2024―Jan―30 |
Beneficial effect of temporary methotrexate interruption on B and T cell responses upon SARS-CoV-2 vaccination in patients with rheumatoid arthritis or psoriatic arthritis |
Pedro Martínez-Fleta, Esther F. Vicente-Rabaneda, Ana Triguero-Martínez, Emilia Roy-Vallejo, Miren Uriarte-Ecenarro, Francisco Gutiérrez-Rodríguez, Patricia Quiroga-Colina, Ana Romero-Robles, Nuria Montes, Noelia García-Castañeda, Gina P. Mejía-Abril, Jesús A. García-Vadillo, Irene Llorente-Cubas, José R. Villagrasa, José M. Serra López-Matencio, Julio Ancochea, Ana Urzainqui, Laura Esparcia-Pinedo, Arantzazu Alfranca, Hortensia de la Fuente, Rosario García-Vicuña, Francisco Sánchez-Madrid, Isidoro González-Álvaro, Santos Castañeda |
| 70 |
[GO] |
2024―Jan―26 |
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans |
Leonie Mayer, Leonie M. Weskamm, Anahita Fathi, Maya Kono, Jasmin Heidepriem, Verena Krähling, Sibylle C. Mellinghoff, My Linh Ly, Monika Friedrich, Svenja Hardtke, Saskia Borregaard, Thomas Hesterkamp, Felix F. Loeffler, Asisa Volz, Gerd Sutter, Stephan Becker, Christine Dahlke, Marylyn M. Addo |
| 71 |
[GO] |
2024―Jan―20 |
Three immunizations with Novavax’s protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2 |
Klara Lenart, Rodrigo Arcoverde Cerveira, Fredrika Hellgren, Sebastian Ols, Daniel J. Sheward, Changil Kim, Alberto Cagigi, Matthew Gagne, Brandon Davis, Daritza Germosen, Vicky Roy, Galit Alter, Hélène Letscher, Jérôme Van Wassenhove, Wesley Gros, Anne-Sophie Gallouët, Roger Le Grand, Harry Kleanthous, Mimi Guebre-Xabier, Ben Murrell, Nita Patel, Gregory Glenn, Gale Smith, Karin Loré |
| 72 |
[GO] |
2024―Jan―05 |
Boosting with adjuvanted SCB-2019 elicits superior Fcγ-receptor engagement driven by IgG3 to SARS-CoV-2 spike |
Wonyeong Jung, Dansu Yuan, Benjamin Kellman, Isabela Garrido da Silva Gonzalez, Ralf Clemens, Eveline Pipolo Milan, Eduardo Sprinz, José Cerbino Neto, Igor Smolenov, Galit Alter, Ryan P. McNamara, Sue Ann Costa Clemens |
| 73 |
[GO] |
2024―Jan―02 |
An mRNA vaccine encoding the SARS-CoV-2 receptor-binding domain protects mice from various Omicron variants |
Ryuta Uraki, Masaki Imai, Mutsumi Ito, Seiya Yamayoshi, Maki Kiso, Nao Jounai, Kazuki Miyaji, Kiyoko Iwatsuki-Horimoto, Fumihiko Takeshita, Yoshihiro Kawaoka |
| 74 |
[GO] |
2024―Jan―02 |
Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial |
Manon L. M. Prins, Geert V. T. Roozen, Cilia. R. Pothast, Wesley Huisman, Rob van Binnendijk, Gerco den Hartog, Vincent P. Kuiper, Corine Prins, Jacqueline J. Janse, Olivia. A. C. Lamers, Jan Pieter R. Koopman, Annelieke C. Kruithof, Ingrid M. C. Kamerling, Romy C. Dijkland, Alicia. C. de Kroon, Shohreh Azimi, Mariet C. W. Feltkamp, Marjan Kuijer, Simon P. Jochems, Mirjam H. M. Heemskerk, Frits R. Rosendaal, Meta Roestenberg, Leo G. Visser, Anna H. E. Roukens |
| 75 |
[GO] |
2023―Nov―23 |
Ischemic stroke after COVID-19 bivalent vaccine administration in patients aged 65 years and older in the United States |
Maria P. Gorenflo, Pamela B. Davis, David C. Kaelber, Rong Xu |
| 76 |
[GO] |
2023―Nov―20 |
Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants |
Chon Phin Ong, Kaiming Tang, Pak-Hin Hinson Cheung, Hongzhuo Zhang, Tze-Tung Tang, Yaqian Xue, Junjue Wang, Kelvin Kai-Wang To, Shuofeng Yuan, Zi-Wei Ye, Dong-Yan Jin |
| 77 |
[GO] |
2023―Nov―20 |
Outlook of pandemic preparedness in a post-COVID-19 world |
B. Adam Williams, Charles H. Jones, Verna Welch, Jane M. True |
| 78 |
[GO] |
2023―Oct―26 |
Human in vitro modeling of adjuvant formulations demonstrates enhancement of immune responses to SARS-CoV-2 antigen |
Simon Doss-Gollin, Sanya Thomas, Byron Brook, Kimia Abedi, Célia Lebas, Floriane Auderset, Yamile Lugo-Rodriguez, Guzman Sanchez-Schmitz, David J. Dowling, Ofer Levy, Simon D. van Haren |
| 79 |
[GO] |
2023―Oct―25 |
Enhanced protective efficacy of a thermostable RBD-S2 vaccine formulation against SARS-CoV-2 and its variants |
Nidhi Mittal, Sahil Kumar, Raju S. Rajmani, Randhir Singh, Céline Lemoine, Virginie Jakob, Sowrabha BJ, Nayana Jagannath, Madhuraj Bhat, Debajyoti Chakraborty, Suman Pandey, Aurélie Jory, Suba Soundarya SA, Harry Kleanthous, Patrice Dubois, Rajesh P. Ringe, Raghavan Varadarajan |
| 80 |
[GO] |
2023―Oct―20 |
Systematic review and meta-analysis of the factors affecting waning of post-vaccination neutralizing antibody responses against SARS-CoV-2 |
Henning Jacobsen, Ioannis Sitaras, Maeva Katzmarzyk, Viviana Cobos Jiménez, Robert Naughton, Melissa M. Higdon, Maria Deloria Knoll |
| 81 |
[GO] |
2023―Oct―20 |
A single-dose of intranasal vaccination with a live-attenuated SARS-CoV-2 vaccine candidate promotes protective mucosal and systemic immunity |
Awadalkareem Adam, Birte Kalveram, John Yun-Chung Chen, Jason Yeung, Leslie Rodriguez, Ankita Singh, Pei-Yong Shi, Xuping Xie, Tian Wang |
| 82 |
[GO] |
2023―Oct―11 |
Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability |
Lizhou Zhang, Kunal R. More, Amrita Ojha, Cody B. Jackson, Brian D. Quinlan, Hao Li, Wenhui He, Michael Farzan, Norbert Pardi, Hyeryun Choe |
| 83 |
[GO] |
2023―Oct―09 |
Lyophilization process optimization and molecular dynamics simulation of mRNA-LNPs for SARS-CoV-2 vaccine |
Mingyuan Li, Lin Jia, Yanbo Xie, Wenlin Ma, Zhihong Yan, Fufeng Liu, Jie Deng, Ali Zhu, Xue Siwei, Wen Su, Xiaofeng Liu, Shiqin Li, Haomeng Wang, Peng Yu, Tao Zhu |
| 84 |
[GO] |
2023―Oct―05 |
COVID-19 mRNA vaccine-mediated antibodies in human breast milk and their association with breast milk microbiota composition |
Shilin Zhao, Kris Y. W. Lok, Zhen Y. Sin, Ye Peng, Heidi S. L. Fan, Nitya Nagesh, Martha S. L. Choi, Jojo Y. Y. Kwok, Edmond P. H. Choi, Xi Zhang, Hogan Kok-Fung Wai, Leo C. H. Tsang, Samuel S. M. Cheng, Matthew K. L. Wong, Jie Zhu, Chris K. P. Mok, Siew C. Ng, Francis K. L. Chan, Malik Peiris, Leo L. M. Poon, Hein M. Tun |
| 85 |
[GO] |
2023―Oct―04 |
Cross-protection and cross-neutralization capacity of ancestral and VOC-matched SARS-CoV-2 adenoviral vector-based vaccines |
Sabrina E. Vinzón, María V. Lopez, Eduardo G. A. Cafferata, Ariadna S. Soto, Paula M. Berguer, Luciana Vazquez, Leonora Nusblat, Andrea V. Pontoriero, Eduardo M. Belotti, Natalia R. Salvetti, Diego L. Viale, Ariel E. Vilardo, Martin M. Avaro, Estefanía Benedetti, Mara L. Russo, María E. Dattero, Mauricio Carobene, Maximiliano Sánchez-Lamas, Jimena Afonso, Mauro Heitrich, Alejandro E. Cristófalo, Lisandro H. Otero, Elsa G. Baumeister, Hugo H. Ortega, Alexis Edelstein, Osvaldo L. Podhajcer |
| 86 |
[GO] |
2023―Sep―29 |
Effect of monovalent COVID-19 vaccines on viral interference between SARS-CoV-2 and several DNA viruses in patients with long-COVID syndrome |
Mariann Gyöngyösi, Dominika Lukovic, Julia Mester-Tonczar, Katrin Zlabinger, Patrick Einzinger, Andreas Spannbauer, Victor Schweiger, Katharina Schefberger, Eslam Samaha, Jutta Bergler-Klein, Martin Riesenhuber, Christian Nitsche, Christian Hengstenberg, Patrick Mucher, Helmuth Haslacher, Monika Breuer, Robert Strassl, Elisabeth Puchhammer-Stöckl, Christian Loewe, Dietrich Beitzke, Ena Hasimbegovic, Thomas A. Zelniker |
| 87 |
[GO] |
2023―Sep―29 |
Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2 |
Lorna Leal, Judit Pich, Laura Ferrer, Jocelyn Nava, Ruth Martí-Lluch, Ignasi Esteban, Edwards Pradenas, Dàlia Raïch-Regué, Antoni Prenafeta, Karla Escobar, Carmen Pastor, Marc Ribas-Aulinas, Benjamin Trinitè, Jordana Muñoz-Basagoiti, Gemma Domenech, Bonaventura Clotet, Júlia Corominas, Aida Corpes-Comes, Carme Garriga, Antonio Barreiro, Nuria Izquierdo-Useros, Joan Albert Arnaiz, Alex Soriano, José Ríos, Marga Nadal, Montserrat Plana, Julià Blanco, Teresa Prat, Elia Torroella, Rafel Ramos, Eva Bonfill, Omar Anagua, Faisury Caicedo, Clara Castán, Fauno Guazina, Sara Messeguer, Marta Aldea, Anna Vilella, Sandra Serrano, Lorna Leal, Judit Pich, Jocelyn Nava, Karla Escobar, Joan Albert Arnaiz, Alex Soriano, José Ríos, Teresa Botta, Ignasi Esteban, Carmen Pastor, Montserrat Plana, Gemma Domenech, Silvia Marfil, Carla Rovirosa, Raquel Ortiz, Daniel Perez-Zsolt, Marçal Gallemí, Edwards Pradenas, Dàlia Raïch-Regué, Benjamin Trinité, Jordana Muñoz-Basagoiti, Bonaventura Clotet, Nuria Izquierdo-Useros, Julià Blanco, Marina González del Río, Ruth Martí-Lluch, Marc Ribas-Aulinas, Aida Corpes-Comes, Marga Nadal, Rafel Ramos, Luís González, Manuel Cañete, Laia Madrenas, Alexandra Moros, Irina Güell, Laura Ferrer, Antoni Prenafeta, Júlia Corominas, Carme Garriga, Antonio Barreiro, Teresa Prat, Elia Torroella |
| 88 |
[GO] |
2023―Sep―27 |
Duration of SARS-CoV-2 mRNA vaccine persistence and factors associated with cardiac involvement in recently vaccinated patients |
Aram J. Krauson, Faye Victoria C. Casimero, Zakir Siddiquee, James R. Stone |
| 89 |
[GO] |
2023―Sep―14 |
Polyfunctional CD4 T-cells correlating with neutralising antibody is a hallmark of COVISHIELDTM and COVAXIN® induced immunity in COVID-19 exposed Indians |
Srabanti Rakshit, Sudhir Babji, Chaitra Parthiban, Ramya Madhavan, Vasista Adiga, Sharon Eveline J, Nirutha Chetan Kumar, Asma Ahmed, Sudarshan Shivalingaiah, Nandini Shashikumar, Mamatha V, Avita Rose Johnson, Naveen Ramesh, Ramkrishna Goud B, Mangaiarkarasi Asokan, Satyajit Mayor, Gagandeep Kang, George D’souza, Mary Dias, Annapurna Vyakarnam |
| 90 |
[GO] |
2023―Sep―01 |
Identifying a causal link between prolactin signaling pathways and COVID-19 vaccine-induced menstrual changes |
Rima Hajjo, Ensaf Momani, Dima A. Sabbah, Nancy Baker, Alexander Tropsha |
| 91 |
[GO] |
2023―Aug―12 |
Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cells |
Robert G. E. Krause, Thandeka Moyo-Gwete, Simone I. Richardson, Zanele Makhado, Nelia P. Manamela, Tandile Hermanus, Nonhlanhla N. Mkhize, Roanne Keeton, Ntombi Benede, Mathilda Mennen, Sango Skelem, Farina Karim, Khadija Khan, Catherine Riou, Ntobeko A. B. Ntusi, Ameena Goga, Glenda Gray, Willem Hanekom, Nigel Garrett, Linda-Gail Bekker, Andreas Groll, Alex Sigal, Penny L. Moore, Wendy A. Burgers, Alasdair Leslie |
| 92 |
[GO] |
2023―Aug―08 |
Self-assembling SARS-CoV-2 spike-HBsAg nanoparticles elicit potent and durable neutralizing antibody responses via genetic delivery |
Cuiping Liu, Lingshu Wang, Jonah S. Merriam, Wei Shi, Eun Sung Yang, Yi Zhang, Man Chen, Wing-Pui Kong, Cheng Cheng, Yaroslav Tsybovsky, Tyler Stephens, Raffaello Verardi, Kwanyee Leung, Cody Stein, Adam S. Olia, Darcy R. Harris, Misook Choe, Baoshan Zhang, Barney S. Graham, Peter D. Kwong, Richard A. Koup, Amarendra Pegu, John R. Mascola |
| 93 |
[GO] |
2023―Aug―04 |
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants |
David N. Springer, Michael Bauer, Iris Medits, Jeremy V. Camp, Stephan W. Aberle, Clemens Burtscher, Eva Höltl, Lukas Weseslindtner, Karin Stiasny, Judith H. Aberle |
| 94 |
[GO] |
2023―Jul―15 |
Maternal and neonatal outcomes of COVID-19 vaccination during pregnancy, a systematic review and meta-analysis |
Greg Marchand, Ahmed Taher Masoud, Sandeep Grover, Alexa King, Giovanna Brazil, Hollie Ulibarri, Julia Parise, Amanda Arroyo, Catherine Coriell, Sydnee Goetz, Carmen Moir, Malini Govindan, Atley Moberly, Anna Proctor, Katelyn Sainz, Richard Blumrick |
| 95 |
[GO] |
2023―Jun―29 |
Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice |
Sonia Jangra, Jeffrey J. Landers, Gabriel Laghlali, Raveen Rathnasinghe, Prajakta Warang, Seok-Chan Park, Jessica. J. O’Konek, Gagandeep Singh, Katarzyna W. Janczak, Adolfo García-Sastre, Nandini Arya, Dilara Karadag, James R. Baker, Michael Schotsaert, Pamela T. Wong |
| 96 |
[GO] |
2023―Jun―09 |
Systematic review and meta-analysis of myocarditis and pericarditis in adolescents following COVID-19 BNT162b2 vaccination |
Patrick D. M. C. Katoto, Liliane N. Byamungu, Amanda S. Brand, Jacques L. Tamuzi, Mireille A. M. Kakubu, Charles S. Wiysonge, Glenda Gray |
| 97 |
[GO] |
2023―Jun―02 |
Antiviral effect of SARS-CoV-2 N-specific CD8+ T cells induced in lungs by engineered extracellular vesicles |
Francesco Manfredi, Chiara Chiozzini, Flavia Ferrantelli, Patrizia Leone, Katherina Pugliese, Massimo Spada, Antonio Di Virgilio, Andrea Giovannelli, Mauro Valeri, Andrea Cara, Zuleika Michelini, Mauro Andreotti, Maurizio Federico |
| 98 |
[GO] |
2023―May―24 |
Developmental and reproductive toxicity of a recombinant protein subunit COVID-19 vaccine (ZF2001) in rats |
Yisheng Song, Jinjin Shao, Guangbiao She, Wanqiang Lv, Guoyu Chen, Jing Liu, Lili Zhang, Chengda Zhang, Jiahong Wang, Ruiyu Tian, Lianpan Dai, George F. Gao, Enqi Huang, Lijiang Zhang |
| 99 |
[GO] |
2023―May―17 |
Th1-dominant cytokine responses in kidney patients after COVID-19 vaccination are associated with poor humoral responses |
Yvette den Hartog, S. Reshwan K. Malahe, Wim J. R. Rietdijk, Marjolein Dieterich, Lennert Gommers, Daryl Geers, Susanne Bogers, Debbie van Baarle, Dimitri A. Diavatopoulos, A. Lianne Messchendorp, Renate G. van der Molen, Ester B. M. Remmerswaal, Frederike J. Bemelman, Ron T. Gansevoort, Luuk B. Hilbrands, Jan-Stephan Sanders, Corine H. GeurtsvanKessel, Marcia M. L. Kho, Marlies E. J. Reinders, Rory D. de Vries, Carla C. Baan |
| 100 |
[GO] |
2023―May―13 |
Intranasal COVID-19 vaccine induces respiratory memory T cells and protects K18-hACE mice against SARS-CoV-2 infection |
Béré K. Diallo, Caitlín Ní Chasaide, Ting Y. Wong, Pauline Schmitt, Katherine S. Lee, Kelly Weaver, Olivia Miller, Melissa Cooper, Seyed D. Jazayeri, F. Heath Damron, Kingston H. G. Mills |
| 101 |
[GO] |
2023―May―10 |
Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico |
Samuel Ponce-de-León, Martha Torres, Luis Enrique Soto-Ramírez, Juan José Calva, Patricio Santillán-Doherty, Dora Eugenia Carranza-Salazar, Juan Manuel Carreño, Claudia Carranza, Esmeralda Juárez, Laura E. Carreto-Binaghi, Luis Ramírez-Martínez, Georgina Paz De la Rosa, Rosalía Vigueras-Moreno, Alejandro Ortiz-Stern, Yolanda López-Vidal, Alejandro E. Macías, Jesús Torres-Flores, Oscar Rojas-Martínez, Alejandro Suárez-Martínez, Gustavo Peralta-Sánchez, Hisaaki Kawabata, Irene González-Domínguez, José Luis Martínez-Guevara, Weina Sun, David Sarfati-Mizrahi, Ernesto Soto-Priante, Héctor Elías Chagoya-Cortés, Constantino López-Macías, Felipa Castro-Peralta, Peter Palese, Adolfo García-Sastre, Florian Krammer, Bernardo Lozano-Dubernard |
| 102 |
[GO] |
2023―May―02 |
Risk assessment of retinal vascular occlusion after COVID-19 vaccination |
Jing-Xing Li, Yu-Hsun Wang, Henry Bair, Shu-Bai Hsu, Connie Chen, James Cheng-Chung Wei, Chun-Ju Lin |
| 103 |
[GO] |
2023―Apr―24 |
Adverse effects, perceptions and attitudes related to BNT162b2, mRNA-1273 or JNJ-78436735 SARS-CoV-2 vaccines: Population-based cohort |
Oliver Bürzle, Dominik Menges, Julian D. Maier, Daniel Schams, Milo A. Puhan, Jan Fehr, Tala Ballouz, Anja Frei |
| 104 |
[GO] |
2023―Apr―22 |
Resistance to COVID-19 vaccination and the social contract: evidence from Italy |
Sarah E. Kreps, Douglas L. Kriner |
| 105 |
[GO] |
2023―Apr―12 |
Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities-workshop report |
Jane M. Knisely, Lucas E. Buyon, Rebecca Mandt, Rebecca Farkas, Shobana Balasingam, Karin Bok, Ursula J. Buchholz, M. Patricia D’Souza, Jennifer L. Gordon, Deborah F. L. King, Tung T. Le, Wolfgang W. Leitner, Robert A. Seder, Alkis Togias, Stig Tollefsen, David W. Vaughn, Daniel N. Wolfe, Kimberly L. Taylor, Anthony S. Fauci |
| 106 |
[GO] |
2023―Mar―27 |
Protection from SARS-CoV-2 Variants by MVAs expressing matched or mismatched S administered intranasally to mice |
Catherine A. Cotter, Jeffrey L. Americo, Patricia L. Earl, Bernard Moss |
| 107 |
[GO] |
2023―Mar―26 |
SARS-CoV-2 spike-ferritin-nanoparticle adjuvanted with ALFQ induces long-lived plasma cells and cross-neutralizing antibodies |
Shikha Shrivastava, Joshua M. Carmen, Zhongyan Lu, Shraddha Basu, Rajeshwer S. Sankhala, Wei-Hung Chen, Phuong Nguyen, William C. Chang, Jocelyn King, Courtney Corbitt, Sandra Mayer, Jessica S. Bolton, Alexander Anderson, Isabella Swafford, Guillermo D. Terriquez, Hung V. Trinh, Jiae Kim, Ousman Jobe, Dominic Paquin-Proulx, Gary, R. Matyas, Gregory D. Gromowski, Jeffrey R. Currier, Elke Bergmann-Leitner, Kayvon Modjarrad, Nelson L. Michael, M. Gordon Joyce, Allison M. W. Malloy, Mangala Rao |
| 108 |
[GO] |
2023―Mar―26 |
PF-D-Trimer, a protective SARS-CoV-2 subunit vaccine: immunogenicity and application |
Zhihao Zhang, Jinhu Zhou, Peng Ni, Bing Hu, Normand Jolicoeur, Shuang Deng, Qian Xiao, Qian He, Gai Li, Yan Xia, Mei Liu, Cong Wang, Zhizheng Fang, Nan Xia, Zhe-Rui Zhang, Bo Zhang, Kun Cai, Yan Xu, Binlei Liu |
| 109 |
[GO] |
2023―Mar―16 |
Synthetic multiantigen MVA vaccine COH04S1 and variant-specific derivatives protect Syrian hamsters from SARS-CoV-2 Omicron subvariants |
Felix Wussow, Mindy Kha, Taehyun Kim, Minh Ly, Marcal Yll-Pico, Swagata Kar, Mark G. Lewis, Flavia Chiuppesi, Don J. Diamond |
| 110 |
[GO] |
2023―Mar―11 |
Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine |
David Benkeser, Youyi Fong, Holly E. Janes, Elizabeth J. Kelly, Ian Hirsch, Stephanie Sproule, Ann Marie Stanley, Jill Maaske, Tonya Villafana, Christopher R. Houchens, Karen Martins, Lakshmi Jayashankar, Flora Castellino, Victor Ayala, Christos J. Petropoulos, Andrew Leith, Deanne Haugaard, Bill Webb, Yiwen Lu, Chenchen Yu, Bhavesh Borate, Lars W. P. van der Laan, Nima S. Hejazi, Lindsay N. Carpp, April K. Randhawa, Michele P. Andrasik, James G. Kublin, Margaret Brewinski Isaacs, Mamodikoe Makhene, Tina Tong, Merlin L. Robb, Lawrence Corey, Kathleen M. Neuzil, Dean Follmann, Corey Hoffman, Ann R. Falsey, Magdalena Sobieszczyk, Richard A. Koup, Ruben O. Donis, Peter B. Gilbert |
| 111 |
[GO] |
2023―Mar―06 |
Estimating immunity with mathematical models for SARS-CoV-2 after COVID-19 vaccination |
Yoshifumi Uwamino, Kengo Nagashima, Ayumi Yoshifuji, Shigeru Suga, Mizuho Nagao, Takao Fujisawa, Munekazu Ryuzaki, Yoshiaki Takemoto, Ho Namkoong, Masatoshi Wakui, Hiromichi Matsushita, Naoki Hasegawa, Yasunori Sato, Mitsuru Murata |
| 112 |
[GO] |
2023―Mar―03 |
Publisher Correction: Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice |
Etsuro Nanishi, Francesco Borriello, Hyuk-Soo Seo, Timothy R. O’Meara, Marisa E. McGrath, Yoshine Saito, Jing Chen, Joann Diray-Arce, Kijun Song, Andrew Z. Xu, Soumik Barman, Manisha Menon, Danica Dong, Timothy M. Caradonna, Jared Feldman, Blake M. Hauser, Aaron G. Schmidt, Lindsey R. Baden, Robert K. Ernst, Carly Dillen, Jingyou Yu, Aiquan Chang, Luuk Hilgers, Peter Paul Platenburg, Sirano Dhe-Paganon, Dan H. Barouch, Al Ozonoff, Ivan Zanoni, Matthew B. Frieman, David J. Dowling, Ofer Levy |
| 113 |
[GO] |
2023―Feb―25 |
Incidence determinants and serological correlates of reactive symptoms following SARS-CoV-2 vaccination |
Hayley Holt, David A. Jolliffe, Mohammad Talaei, Sian Faustini, Giulia Vivaldi, Matthew Greenig, Alex G. Richter, Ronan A. Lyons, Christopher J. Griffiths, Frank Kee, Aziz Sheikh, Gwyneth A. Davies, Seif O. Shaheen, Adrian R. Martineau |
| 114 |
[GO] |
2023―Feb―23 |
Independent control of COVID-19 vaccines by EU Official Control Authority Batch Release: challenges, strengths and successes |
Catherine Milne, Ralf Wagner, François Cano, Martijn Bruysters, Geneviève Waeterloos, Dieter Pullirsch, Michael Wierer, Laurent Mallet |
| 115 |
[GO] |
2023―Feb―23 |
Immunogenicity and protective efficacy of GBP510/AS03 vaccine against SARS-CoV-2 delta challenge in rhesus macaques |
Catherine Jacob-Dolan, Jingyou Yu, Katherine McMahan, Victoria Giffin, Abishek Chandrashekar, Amanda J. Martinot, Tochi Anioke, Olivia C. Powers, Kevin Hall, David Hope, Jessica Miller, Nichole P. Hachmann, Benjamin Chung, Sarah Gardner, Daniel Sellers, Julia Barrett, Mark G. Lewis, Hanne Andersen, Harry Kleanthous, Ki-Woen Seo, Su Jeen Lee, Yong Wook Park, Hun Kim, Dan H. Barouch |
| 116 |
[GO] |
2023―Feb―14 |
Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice |
Etsuro Nanishi, Francesco Borriello, Hyuk-Soo Seo, Timothy R. O’Meara, Marisa E. McGrath, Yoshine Saito, Jing Chen, Joann Diray-Arce, Kijun Song, Andrew Z. Xu, Soumik Barman, Manisha Menon, Danica Dong, Timothy M. Caradonna, Jared Feldman, Blake M. Hauser, Aaron G. Schmidt, Lindsey R. Baden, Robert K. Ernst, Carly Dillen, Jingyou Yu, Aiquan Chang, Luuk Hilgers, Peter Paul Platenburg, Sirano Dhe-Paganon, Dan H. Barouch, Al Ozonoff, Ivan Zanoni, Matthew B. Frieman, David J. Dowling, Ofer Levy |
| 117 |
[GO] |
2023―Feb―13 |
Robust induction of functional humoral response by a plant-derived Coronavirus-like particle vaccine candidate for COVID-19 |
Paulina Kaplonek, Deniz Cizmeci, Jessica Shih-Lu Lee, Sally A. Shin, Stephanie Fischinger, Philipe Gobeil, Stéphane Pillet, Nathalie Charland, Brian J. Ward, Galit Alter |
| 118 |
[GO] |
2023―Feb―13 |
Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern |
Patrick O. Azevedo, Natália S. Hojo-Souza, Lídia P. Faustino, Marcílio J. Fumagalli, Isabella C. Hirako, Emiliano R. Oliveira, Maria M. Figueiredo, Alex F. Carvalho, Daniel Doro, Luciana Benevides, Edison Durigon, Flávio Fonseca, Alexandre M. Machado, Ana P. Fernandes, Santuza R. Teixeira, João S. Silva, Ricardo T. Gazzinelli |
| 119 |
[GO] |
2023―Feb―02 |
Is partisan conflict over COVID-19 vaccination eroding support for childhood vaccine mandates? |
Matt Motta |
| 120 |
[GO] |
2023―Feb―02 |
Author Correction: “World in motion” - emulsion adjuvants rising to meet the pandemic challenges |
Derek T. O’Hagan, Robbert van der Most, Rushit N. Lodaya, Margherita Coccia, Giuseppe Lofano |
| 121 |
[GO] |
2023―Jan―25 |
Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants |
Trung The Tran, Eline Benno Vaage, Adi Mehta, Adity Chopra, Lisa Tietze, Anette Kolderup, Aina Anthi, Marton König, Gro Nygaard, Andreas Lind, Fredrik Müller, Lise Sofie Nissen-Meyer, Per Magnus, Lill Trogstad, Siri Mjaaland, Arne Søraas, Karsten Midtvedt, Anders Åsberg, Andreas Barratt-Due, Asle W. Medhus, Marte Lie Høivik, Knut Lundin, Randi Fuglaas Karlsen, Reidun Dahle, Karin Danielsson, Kristine Stien Thomassen, Grete Birkeland Kro, Rebecca J. Cox, Fan Zhou, Nina Langeland, Pål Aukrust, Espen Melum, Tone Lise Åvitsland, Kristine Wiencke, Jan Cato Holter, Ludvig A. Munthe, Gunnveig Grødeland, Jan-Terje Andersen, John Torgils Vaage, Fridtjof Lund-Johansen |
| 122 |
[GO] |
2022―Dec―30 |
Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants |
Trung The Tran, Eline Benno Vaage, Adi Mehta, Adity Chopra, Lisa Tietze, Anette Kolderup, Aina Anthi, Marton König, Gro Nygaard, Andreas Lind, Fredrik Müller, Lise Sofie Nissen-Meyer, Per Magnus, Lill Trogstad, Siri Mjaaland, Arne Søraas, Karsten Midtvedt, Anders Åsberg, Andreas Barratt-Due, Asle W. Medhus, Marte Lie Høivk, Knut Lundin, Randi Fuglaas Karlsen, Reidun Dahle, Karin Danielsson, Kristine Stien Thomassen, Grete Birkeland Kro, Rebecca J. Cox, Fan Zhou, Nina Langeland, Pål Aukrust, Espen Melum, Tone Lise Åvitsland, Kristine Wiencke, Jan Cato Holter, Ludvig A. Munthe, Gunnveig Grødeland, Jan-Terje Andersen, John Torgils Vaage, Fridtjof Lund-Johansen |
| 123 |
[GO] |
2022―Dec―19 |
Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern |
Juan Shi, Gang Wang, Jian Zheng, Abhishek K. Verma, Xiaoqing Guan, Moffat M. Malisheni, Qibin Geng, Fang Li, Stanley Perlman, Lanying Du |
| 124 |
[GO] |
2022―Dec―19 |
Challenges and developments in universal vaccine design against SARS-CoV-2 variants |
Fangxin Zhao, Xiaodong Zai, Zhiling Zhang, Junjie Xu, Wei Chen |
| 125 |
[GO] |
2022―Dec―16 |
Safety and immunogenicity of SARS-CoV-2 vaccine MVC-COV1901 in Taiwanese adolescents: a randomized phase 2 trial |
Luke Tzu-Chi Liu, Cheng-Hsun Chiu, Nan-Chang Chiu, Boon-Fatt Tan, Chien-Yu Lin, Hao-Yuan Cheng, Meei-Yun Lin, Chia-En Lien, Charles Chen, Li-Min Huang |
| 126 |
[GO] |
2022―Dec―15 |
Comparing hybrid and regular COVID-19 vaccine-induced immunity against the Omicron epidemic |
Lei Huang, Francisco Tsz Tsun Lai, Vincent Ka Chun Yan, Franco Wing Tak Cheng, Ching Lung Cheung, Celine Sze Ling Chui, Xue Li, Eric Yuk Fai Wan, Carlos King Ho Wong, Ivan Fan Ngai Hung, Chak Sing Lau, Ian Chi Kei Wong, Esther Wai Yin Chan |
| 127 |
[GO] |
2022―Dec―13 |
A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine |
Jenny G. Low, Ruklanthi de Alwis, Shiwei Chen, Shirin Kalimuddin, Yan Shan Leong, Tania Ken Lin Mah, Natalene Yuen, Hwee Cheng Tan, Summer L. Zhang, Jean X. Y. Sim, Yvonne F. Z. Chan, Ayesa Syenina, Jia Xin Yee, Eugenia Z. Ong, Rose Sekulovich, Brian B. Sullivan, Kelly Lindert, Sean M. Sullivan, Pad Chivukula, Steven G. Hughes, Eng Eong Ooi |
| 128 |
[GO] |
2022―Dec―03 |
BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children |
Yannic C. Bartsch, Jessica W. Chen, Jaewon Kang, Madeleine D. Burns, Kerri J. St Denis, Maegan L. Sheehan, Jameson P. Davis, Andrea G. Edlow, Alejandro B. Balazs, Lael M. Yonker, Galit Alter |
| 129 |
[GO] |
2022―Nov―28 |
Immune gene expression analysis indicates the potential of a self-amplifying Covid-19 mRNA vaccine |
Eugenia Z. Ong, Jia Xin Yee, Justin S. G. Ooi, Ayesa Syenina, Ruklanthi de Alwis, Shiwei Chen, Jean X. Y. Sim, Shirin Kalimuddin, Yan Shan Leong, Yvonne F. Z. Chan, Rose Sekulovich, Brian M. Sullivan, Kelly Lindert, Sean B. Sullivan, Pad Chivukula, Steven G. Hughes, Jenny G. Low, Eng Eong Ooi, Kuan Rong Chan |
| 130 |
[GO] |
2022―Nov―24 |
Author Correction: A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability |
Emily A. Voigt, Alana Gerhardt, Derek Hanson, Madeleine F. Jennewein, Peter Battisti, Sierra Reed, Jasneet Singh, Raodoh Mohamath, Julie Bakken, Samuel Beaver, Christopher Press, Patrick Soon-Shiong, Christopher J. Paddon, Christopher B. Fox, Corey Casper |
| 131 |
[GO] |
2022―Nov―15 |
Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant |
Ioannis Sitaras, Henning Jacobsen, Melissa M. Higdon, William E. Dowling, Naor Bar-Zeev, Maria Deloria Knoll |
| 132 |
[GO] |
2022―Nov―15 |
Impaired neutralizing antibodies and preserved cellular immunogenicity against SARS-CoV-2 in systemic autoimmune rheumatic diseases |
Porntip Intapiboon, Parichat Uae-areewongsa, Jomkwan Ongarj, Ratchanon Sophonmanee, Purilap Seepathomnarong, Bunya Seeyankem, Smonrapat Surasombatpattana, Nawamin Pinpathomrat |
| 133 |
[GO] |
2022―Nov―15 |
Anti-Ad26 humoral immunity does not compromise SARS-COV-2 neutralizing antibody responses following Gam-COVID-Vac booster vaccination |
Maria G. Byazrova, Ekaterina A. Astakhova, Aygul R. Minnegalieva, Maria M. Sukhova, Artem A. Mikhailov, Alexey G. Prilipov, Andrey A. Gorchakov, Alexander V. Filatov |
| 134 |
[GO] |
2022―Nov―12 |
A potent, broadly protective vaccine against SARS-CoV-2 variants of concern |
Ziyan Wang, Jiao An, Kunpeng Liu, Pin Yu, Xin Fang, Jiadai Li, Hua Zhu, Qianjun Zhu, Chuanqi Huang, Chao Zhang, Binbin Zhao, Linlin Bao, Yujiao Song, Xiayao Cao, Dongdong Hu, Yuanxiang Jiang, Likang Shi, Lingyun Zhou, Jiang Fan, Wuxiang Guan, Chenliang Zhou, Zhongyu Hu, Zhiming Yuan, Jiangning Liu, Chao Shan, Ge Liu |
| 135 |
[GO] |
2022―Nov―09 |
Understanding thrombosis with thrombocytopenia syndrome after COVID-19 vaccination |
Alessandra Buoninfante, Arno Andeweg, Alexander T. Baker, Mitesh Borad, Nigel Crawford, Jean-Michel Dogné, David Garcia-Azorin, Andreas Greinacher, Rita Helfand, Anders Hviid, Stefan Kochanek, Marta López-Fauqued, Ishac Nazy, Anand Padmanabhan, Sue Pavord, Daniel Prieto-Alhambra, Huyen Tran, Ulla Wandel Liminga, Marco Cavaleri |
| 136 |
[GO] |
2022―Nov―09 |
Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without Comorbidities |
Nathalie Charland, Philipe Gobeil, Stéphane Pillet, Iohann Boulay, Annie Séguin, Alexander Makarkov, Gretchen Heizer, Kapil Bhutada, Asif Mahmood, Sonia Trépanier, Karen Hager, Julia Jiang-Wright, Judith Atkins, Pooja Saxena, Matthew P. Cheng, Donald C. Vinh, Philippe Boutet, François Roman, Robbert Van Der Most, Maria Angeles Ceregido, Marc Dionne, Guy Tellier, Jean-Sébastien Gauthier, Brandon Essink, Michael Libman, Jason Haffizulla, André Fréchette, Marc-André D’Aoust, Nathalie Landry, Brian J. Ward |
| 137 |
[GO] |
2022―Nov―02 |
A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability |
Emily A. Voigt, Alana Gerhardt, Derek Hanson, Madeleine F. Jennewein, Peter Battisti, Sierra Reed, Jasneet Singh, Raodoh Mohamath, Julie Bakken, Samuel Beaver, Christopher Press, Patrick Soon-Shiong, Christopher J. Paddon, Christopher B. Fox, Corey Casper |
| 138 |
[GO] |
2022―Oct―28 |
Amphiphile-CpG vaccination induces potent lymph node activation and COVID-19 immunity in mice and non-human primates |
Lochana M. Seenappa, Aniela Jakubowski, Martin P. Steinbuck, Erica Palmer, Christopher M. Haqq, Crystal Carter, Jane Fontenot, Francois Villinger, Lisa K. McNeil, Peter C. DeMuth |
| 139 |
[GO] |
2022―Oct―27 |
Immunogenicity and protective efficacy of a rhesus adenoviral vaccine targeting conserved COVID-19 replication transcription complex |
Gabriel Dagotto, John D. Ventura, David R. Martinez, Tochi Anioke, Benjamin S. Chung, Mazuba Siamatu, Julia Barrett, Jessica Miller, Alexandra Schäfer, Jingyou Yu, Lisa H. Tostanoski, Kshitij Wagh, Ralph S. Baric, Bette Korber, Dan H. Barouch |
| 140 |
[GO] |
2022―Oct―21 |
Moderate to severe SARS-CoV-2 infection primes vaccine-induced immunity more effectively than asymptomatic or mild infection |
Kayla A. Holder, Danielle P. Ings, Debbie O. A. Harnum, Rodney S. Russell, Michael D. Grant |
| 141 |
[GO] |
2022―Oct―12 |
Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern |
Bassel Akache, Tyler M. Renner, Matthew Stuible, Nazanin Rohani, Yuneivy Cepero-Donates, Lise Deschatelets, Renu Dudani, Blair A. Harrison, Christian Gervais, Jennifer J. Hill, Usha D. Hemraz, Edmond Lam, Sophie Régnier, Anne E. G. Lenferink, Yves Durocher, Michael J. McCluskie |
| 142 |
[GO] |
2022―Oct―01 |
Understanding change in COVID-19 vaccination intention with network analysis of longitudinal data from Dutch adults |
Monique Chambon, Wesley G. Kammeraad, Frenk van Harreveld, Jonas Dalege, Janneke E. Elberse, Han L. J. van der Maas |
| 143 |
[GO] |
2022―Sep―23 |
Inactivated rabies-vectored SARS-CoV-2 vaccine provides long-term immune response unaffected by vector immunity |
Catherine Yankowski, Christoph Wirblich, Drishya Kurup, Matthias J. Schnell |
| 144 |
[GO] |
2022―Sep―06 |
Author Correction: Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population |
Nawamin Pinpathomrat, Porntip Intapiboon, Purilap Seepathomnarong, Jomkwan Ongarj, Ratchanon Sophonmanee, Jariya Hengprakop, Smonrapat Surasombatpattana, Supattra Uppanisakorn, Surakameth Mahasirimongkol, Waritta Sawaengdee, Supaporn Phumiamorn, Sompong Sapsutthipas, Chanon Kongkamol, Thammasin Ingviya, Pasuree Sangsupawanich, Sarunyou Chusri |
| 145 |
[GO] |
2022―Sep―02 |
SARS-CoV-2 mRNA-vaccine candidate; COReNAPCIN®, induces robust humoral and cellular immunity in mice and non-human primates |
Reza Alimohammadi, Meysam Porgoo, Mohamad Eftekhary, Seyed Hossein Kiaie, Ehsan Ansari Dezfouli, Maryam Dehghani, Kaveh Nasrollahi, Talieh Malekshahabi, Maryam Heidari, Sedigheh Pouya, Masoumeh Alimohammadi, Dorsa Sattari Khavas, Mohammad Sadra Modaresi, Mohammad Hossein Ghasemi, Hamed Ramyar, Fatemeh Mohammadipour, Fateme Hamzelouei, Ahmadreza Mofayezi, Seyed Saeed Mottaghi, Amirhosein Rahmati, Mohsen Razzaznian, Vista Tirandazi, Mahdi Tat, Fatemeh Borzouee, Hossein Sadeghi, Melika Haji Mohammadi, Leila Rastegar, Seyed Milad Safar Sajadi, Hossein Ehsanbakhsh, Hamed Bazmbar, Zeinab Baghernejadan, Maedeh Shams Nouraei, Pouya Pazooki, Mina Pahlavanneshan, Khadijeh Alishah, Fateme Nasiri, Neda Mokhberian, Seyedeh Shima Mohammadi, Shima Akar, Hamidreza Niknam, Marzieh Azizi, Mohammad Ajoudanian, Mohammad Hossein Moteallehi-Ardakani, Seyed Ali Mousavi Shaegh, Reihaneh Ramezani, Vahid Salimi, Reza Moazzami, Seyed Mahmoud Hashemi, Somaye Dehghanizadeh, Vahid Khoddami |
| 146 |
[GO] |
2022―Aug―19 |
Publisher Correction: An immunological autobiography: my year as a COVID-19 vaccine trial participant |
Ross M. Kedl |
| 147 |
[GO] |
2022―Aug―11 |
A Bayesian network analysis quantifying risks versus benefits of the Pfizer COVID-19 vaccine in Australia |
Jane E. Sinclair, Helen J. Mayfield, Kirsty R. Short, Samuel J. Brown, Rajesh Puranik, Kerrie Mengersen, John C. B. Litt, Colleen L. Lau |
| 148 |
[GO] |
2022―Aug―02 |
Affordable SARS-CoV-2 protein vaccines for the pandemic endgame |
James A. Triccas, Joeri Kint, Florian M. Wurm |
| 149 |
[GO] |
2022―Jul―29 |
Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2 |
Mariana F. Tioni, Robert Jordan, Angie Silva Pena, Aditya Garg, Danlu Wu, Shannon I. Phan, Christopher M. Weiss, Xing Cheng, Jack Greenhouse, Tatyana Orekov, Daniel Valentin, Swagata Kar, Laurent Pessaint, Hanne Andersen, Christopher C. Stobart, Melissa H. Bloodworth, R. Stokes Peebles, Yang Liu, Xuping Xie, Pei-Yong Shi, Martin L. Moore, Roderick S. Tang |
| 150 |
[GO] |
2022―Jul―26 |
Rational development of a combined mRNA vaccine against COVID-19 and influenza |
Qing Ye, Mei Wu, Chao Zhou, Xishan Lu, Baoying Huang, Ning Zhang, Hui Zhao, Hang Chi, Xiaojing Zhang, Dandan Ling, Rong-Rong Zhang, Zhuofan Li, Dan Luo, Yi-Jiao Huang, Hong-Ying Qiu, Haifeng Song, Wenjie Tan, Ke Xu, Bo Ying, Cheng-Feng Qin |
| 151 |
[GO] |
2022―Jul―25 |
Optimized intramuscular immunization with VSV-vectored spike protein triggers a superior immune response to SARS-CoV-2 |
Adriano Taddeo, Inês Berenguer Veiga, Christelle Devisme, Renate Boss, Philippe Plattet, Sebastian Weigang, Georg Kochs, Volker Thiel, Charaf Benarafa, Gert Zimmer |
| 152 |
[GO] |
2022―Jul―18 |
An immunological autobiography: my year as a COVID-19 vaccine trial participant |
Ross M. Kedl |
| 153 |
[GO] |
2022―Jul―06 |
Comparative analysis of human immune responses following SARS-CoV-2 vaccination with BNT162b2, mRNA-1273, or Ad26.COV2.S |
Dominique J. Barbeau, Judith M. Martin, Emily Carney, Emily Dougherty, Joshua D. Doyle, Terence S. Dermody, Alejandro Hoberman, John V. Williams, Marian G. Michaels, John F. Alcorn, W. Paul Duprex, Anita K. McElroy |
| 154 |
[GO] |
2022―Jun―28 |
Intranasal immunization with avian paramyxovirus type 3 expressing SARS-CoV-2 spike protein protects hamsters against SARS-CoV-2 |
Hong-Su Park, Yumiko Matsuoka, Cindy Luongo, Lijuan Yang, Celia Santos, Xueqiao Liu, Laura R. H. Ahlers, Ian N. Moore, Sharmin Afroz, Reed F. Johnson, Bernard A. P. Lafont, David W. Dorward, Elizabeth R. Fischer, Craig Martens, Siba K. Samal, Shirin Munir, Ursula J. Buchholz, Cyril Le Nouën |
| 155 |
[GO] |
2022―Jun―03 |
A DNA vaccine candidate delivered by an electroacupuncture machine provides protective immunity against SARS-CoV-2 infection |
Tsai-Teng Tzeng, Kit Man Chai, Kuan-Yin Shen, Chia-Yi Yu, Shiu-Ju Yang, Wan-Chun Huang, Hung-Chun Liao, Fang-Feng Chiu, Horng-Yunn Dou, Ching-Len Liao, Hsin-Wei Chen, Shih-Jen Liu |
| 156 |
[GO] |
2022―May―26 |
Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease |
Bennett J. Davenport, Alexis Catala, Stuart M. Weston, Robert M. Johnson, Jeremy Ardanuy, Holly L. Hammond, Carly Dillen, Matthew B. Frieman, Carlos E. Catalano, Thomas E. Morrison |
| 157 |
[GO] |
2022―May―25 |
Increased receptor affinity of SARS-CoV-2: a new immune escape mechanism |
Martin F. Bachmann, Mona O. Mohsen, Daniel E. Speiser |
| 158 |
[GO] |
2022―May―23 |
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice |
Lilit Grigoryan, Audrey Lee, Alexandra C. Walls, Lilin Lai, Benjamin Franco, Prabhu S. Arunachalam, Yupeng Feng, Wei Luo, Abigail Vanderheiden, Katharine Floyd, Samuel Wrenn, Deleah Pettie, Marcos C. Miranda, Elizabeth Kepl, Rashmi Ravichandran, Claire Sydeman, Natalie Brunette, Michael Murphy, Brooke Fiala, Lauren Carter, Robert L. Coffman, David Novack, Harry Kleanthous, Derek T. O’Hagan, Robbert van der Most, Jason S. McLellan, Mehul Suthar, David Veesler, Neil P. King, Bali Pulendran |
| 159 |
[GO] |
2022―May―13 |
Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population |
Nawamin Pinpathomrat, Porntip Intapiboon, Purilap Seepathomnarong, Jomkwan Ongarj, Ratchanon Sophonmanee, Jariya Hengprakop, Smonrapat Surasombatpattana, Supattra Uppanisakorn, Surakameth Mahasirimongkol, Waritta Sawaengdee, Supaporn Phumiamorn, Sompong Sapsutthipas, Chanon Kongkamol, Thammasin Ingviya, Pasuree Sangsupawanich, Sarunyou Chusri |
| 160 |
[GO] |
2022―Apr―26 |
Two DNA vaccines protect against severe disease and pathology due to SARS-CoV-2 in Syrian hamsters |
George Giorgi Babuadze, Hugues Fausther-Bovendo, Marc-Antoine deLaVega, Brandon Lillie, Maedeh Naghibosadat, Nariman Shahhosseini, Michael A. Joyce, Holly A. Saffran, D. Lorne Tyrrell, Darryl Falzarano, Chandrika Senthilkumaran, Natasha Christie-Holmes, Steven Ahn, Scott D. Gray-Owen, Arinjay Banerjee, Samira Mubareka, Karen Mossman, Chanel Dupont, Jannie Pedersen, Mark-Alexandre Lafrance, Gary P. Kobinger, Robert Kozak |
| 161 |
[GO] |
2022―Apr―25 |
A single intranasal dose of human parainfluenza virus type 3-vectored vaccine induces effective antibody and memory T cell response in the lungs and protects hamsters against SARS-CoV-2 |
Philipp A. Ilinykh, Sivakumar Periasamy, Kai Huang, Natalia A. Kuzmina, Palaniappan Ramanathan, Michelle N. Meyer, Chad E. Mire, Ivan V. Kuzmin, Preeti Bharaj, Jessica R. Endsley, Maria Chikina, Stuart C. Sealfon, Steven G. Widen, Mark A. Endsley, Alexander Bukreyev |
| 162 |
[GO] |
2022―Apr―08 |
BNT162b2-elicited neutralization of Delta plus, Lambda, Mu, B.1.1.519, and Theta SARS-CoV-2 variants |
Jianying Liu, Yang Liu, Hongjie Xia, Jing Zou, Scott C. Weaver, Kena A. Swanson, Hui Cai, Mark Cutler, David Cooper, Alexander Muik, Kathrin U. Jansen, Ugur Sahin, Xuping Xie, Philip R. Dormitzer, Pei-Yong Shi |
| 163 |
[GO] |
2022―Mar―14 |
Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge |
Ting Y. Wong, Katherine S. Lee, Brynnan P. Russ, Alexander M. Horspool, Jason Kang, Michael T. Winters, M. Allison Wolf, Nathaniel A. Rader, Olivia A. Miller, Morgane Shiflett, Jerilyn Izac, David Varisco, Emel Sen-Kilic, Casey Cunningham, Melissa Cooper, Holly A. Cyphert, Mariette Barbier, Ivan Martinez, Justin R. Bevere, Robert K. Ernst, F. Heath Damron |
| 164 |
[GO] |
2022―Mar―08 |
Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant |
Kevin K. Ariën, Leo Heyndrickx, Johan Michiels, Katleen Vereecken, Kurt Van Lent, Sandra Coppens, Betty Willems, Pieter Pannus, Geert A. Martens, Marjan Van Esbroeck, Maria E. Goossens, Arnaud Marchant, Koen Bartholomeeusen, Isabelle Desombere |
| 165 |
[GO] |
2022―Mar―02 |
Use of analgesics/antipyretics in the management of symptoms associated with COVID-19 vaccination |
Eng Eong Ooi, Arti Dhar, Richard Petruschke, Camille Locht, Philippe Buchy, Jenny Guek Hong Low |
| 166 |
[GO] |
2022―Mar―02 |
Pandemic-response adenoviral vector and RNA vaccine manufacturing |
Zoltán Kis, Kyungjae Tak, Dauda Ibrahim, Maria M. Papathanasiou, Benoît Chachuat, Nilay Shah, Cleo Kontoravdi |
| 167 |
[GO] |
2022―Feb―28 |
Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy |
Zabrina L. Brumme, Francis Mwimanzi, Hope R. Lapointe, Peter K. Cheung, Yurou Sang, Maggie C. Duncan, Fatima Yaseen, Olga Agafitei, Siobhan Ennis, Kurtis Ng, Simran Basra, Li Yi Lim, Rebecca Kalikawe, Sarah Speckmaier, Nadia Moran-Garcia, Landon Young, Hesham Ali, Bruce Ganase, Gisele Umviligihozo, F. Harrison Omondi, Kieran Atkinson, Hanwei Sudderuddin, Junine Toy, Paul Sereda, Laura Burns, Cecilia T. Costiniuk, Curtis Cooper, Aslam H. Anis, Victor Leung, Daniel Holmes, Mari L. DeMarco, Janet Simons, Malcolm Hedgcock, Marc G. Romney, Rolando Barrios, Silvia Guillemi, Chanson J. Brumme, Ralph Pantophlet, Julio S. G. Montaner, Masahiro Niikura, Marianne Harris, Mark Hull, Mark A. Brockman |
| 168 |
[GO] |
2022―Feb―23 |
An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission |
Kairat Tabynov, Nurkeldi Turebekov, Meruert Babayeva, Gleb Fomin, Toktassyn Yerubayev, Tlektes Yespolov, Lei Li, Gourapura J. Renukaradhya, Nikolai Petrovsky, Kaissar Tabynov |
| 169 |
[GO] |
2022―Feb―18 |
Calibrated comparison of SARS-CoV-2 neutralizing antibody levels in response to protein-, mRNA-, and vector-based COVID-19 vaccines |
Michael Karbiener, Maria R. Farcet, Andreas Zollner, Taisei Masuda, Mitsuhiro Mori, Alexander R. Moschen, Thomas R. Kreil |
| 170 |
[GO] |
2022―Feb―09 |
Full efficacy and long-term immunogenicity induced by the SARS-CoV-2 vaccine candidate MVA-CoV2-S in mice |
Adrián Lázaro-Frías, Patricia Pérez, Carmen Zamora, Pedro J. Sánchez-Cordón, María Guzmán, Joanna Luczkowiak, Rafael Delgado, José M. Casasnovas, Mariano Esteban, Juan García-Arriaza |
| 171 |
[GO] |
2022―Feb―08 |
Circulating extracellular vesicle microRNAs associated with adverse reactions, proinflammatory cytokine, and antibody production after COVID-19 vaccination |
Yusuke Miyashita, Takanobu Yoshida, Yuriko Takagi, Hirotake Tsukamoto, Ken Takashima, Takahisa Kouwaki, Katsunari Makino, Satoshi Fukushima, Kimitoshi Nakamura, Hiroyuki Oshiumi |
| 172 |
[GO] |
2022―Jan―21 |
Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates |
Flavia Chiuppesi, Vu H. Nguyen, Yoonsuh Park, Heidi Contreras, Veronica Karpinski, Katelyn Faircloth, Jenny Nguyen, Mindy Kha, Daisy Johnson, Joy Martinez, Angelina Iniguez, Qiao Zhou, Teodora Kaltcheva, Paul Frankel, Swagata Kar, Ankur Sharma, Hanne Andersen, Mark G. Lewis, Yuriy Shostak, Felix Wussow, Don J. Diamond |
| 173 |
[GO] |
2022―Jan―10 |
Passive transfer of Ad26.COV2.S-elicited IgG from humans attenuates SARS-CoV-2 disease in hamsters |
Lisa H. Tostanoski, Abishek Chandrashekar, Shivani Patel, Jingyou Yu, Catherine Jacob-Dolan, Aiquan Chang, Olivia C. Powers, Daniel Sellers, Sarah Gardner, Julia Barrett, Owen Sanborn, Kathryn E. Stephenson, Jessica L. Ansel, Kate Jaegle, Michael S. Seaman, Maciel Porto, Megan Lok, Brittany Spence, Kathleen Cayer, Danielle Nase, Shaikim Holman, Heath Bradette, Swagata Kar, Hanne Andersen, Mark G. Lewis, Freek Cox, Jeroen T. B. M. Tolboom, Anne Marit de Groot, Dirk Heerwegh, Mathieu Le Gars, Jerald Sadoff, Frank Wegmann, Roland C. Zahn, Hanneke Schuitemaker, Dan H. Barouch |
| 174 |
[GO] |
2021―Dec―21 |
“World in motion” - emulsion adjuvants rising to meet the pandemic challenges |
Derek T. O’Hagan, Robbert van der Most, Rushit N. Lodaya, Margherita Coccia, Giuseppe Lofano |
| 175 |
[GO] |
2021―Dec―20 |
Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2 |
Ria Lassaunière, Charlotta Polacek, Gregers J. Gram, Anders Frische, Jeanette Linnea Tingstedt, Maren Krüger, Brigitte G. Dorner, Anthony Cook, Renita Brown, Tatyana Orekov, Tammy Putmon-Taylor, Tracey-Ann Campbell, Jack Greenhouse, Laurent Pessaint, Hanne Andersen, Mark G. Lewis, Anders Fomsgaard |
| 176 |
[GO] |
2021―Dec―16 |
Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza |
Sudha Chivukula, Timothy Plitnik, Timothy Tibbitts, Shrirang Karve, Anusha Dias, Donghui Zhang, Rebecca Goldman, Hardip Gopani, Asad Khanmohammed, Ashish Sarode, Dustin Cooper, Heesik Yoon, Younghoon Kim, Yanhua Yan, Sophia T. Mundle, Rachel Groppo, Adrien Beauvais, Jinrong Zhang, Natalie G. Anosova, Charles Lai, Lu Li, Gregory Ulinski, Peter Piepenhagen, Joshua DiNapoli, Kirill V. Kalnin, Victoria Landolfi, Ron Swearingen, Tong-Ming Fu, Frank DeRosa, Danilo Casimiro |
| 177 |
[GO] |
2021―Dec―13 |
SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses |
Joshua M. Carmen, Shikha Shrivastava, Zhongyan Lu, Alexander Anderson, Elaine B. Morrison, Rajeshwer S. Sankhala, Wei-Hung Chen, William C. Chang, Jessica S. Bolton, Gary R. Matyas, Nelson L. Michael, M. Gordon Joyce, Kayvon Modjarrad, Jeffrey R. Currier, Elke Bergmann-Leitner, Allison M. W. Malloy, Mangala Rao |
| 178 |
[GO] |
2021―Dec―03 |
MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge |
Clement A. Meseda, Charles B. Stauft, Prabhuanand Selvaraj, Christopher Z. Lien, Cyntia Pedro, Ivette A. Nuñez, Amy M. Woerner, Tony T. Wang, Jerry P. Weir |
| 179 |
[GO] |
2021―Dec―03 |
A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern |
Mitch Brinkkemper, Philip J. M. Brouwer, Pauline Maisonnasse, Marloes Grobben, Tom G. Caniels, Meliawati Poniman, Judith A. Burger, Ilja Bontjer, Melissa Oomen, Joey H. Bouhuijs, Cynthia A. van der Linden, Julien Villaudy, Yme U. van der Velden, Kwinten Sliepen, Marit J. van Gils, Roger Le Grand, Rogier W. Sanders |
| 180 |
[GO] |
2021―Nov―30 |
A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection |
Claudio Counoupas, Matt D. Johansen, Alberto O. Stella, Duc H. Nguyen, Angela L. Ferguson, Anupriya Aggarwal, Nayan D. Bhattacharyya, Alice Grey, Owen Hutchings, Karishma Patel, Rezwan Siddiquee, Erica L. Stewart, Carl G. Feng, Nicole G. Hansbro, Umaimainthan Palendira, Megan C. Steain, Bernadette M. Saunders, Jason K. K. Low, Joel P. Mackay, Anthony D. Kelleher, Warwick J. Britton, Stuart G. Turville, Philip M. Hansbro, James A. Triccas |
| 181 |
[GO] |
2021―Nov―29 |
Mucosal vaccination induces protection against SARS-CoV-2 in the absence of detectable neutralizing antibodies |
Chaojie Zhong, Hongjie Xia, Awadalkareem Adam, Binbin Wang, Renee L. Hajnik, Yuejin Liang, Grace H. Rafael, Jing Zou, Xiaofang Wang, Jiaren Sun, Lynn Soong, Alan D. T. Barrett, Scott C. Weaver, Pei-Yong Shi, Tian Wang, Haitao Hu |
| 182 |
[GO] |
2021―Nov―29 |
Immune response against SARS-CoV-2 variants: the role of neutralization assays |
Alicja Maria Chmielewska, Anna Czarnota, Krystyna Bieńkowska-Szewczyk, Katarzyna Grzyb |
| 183 |
[GO] |
2021―Nov―18 |
Development of COVID-19 vaccine using a dual Toll-like receptor ligand liposome adjuvant |
Mayuresh M. Abhyankar, Barbara J. Mann, Jeffrey M. Sturek, Savannah Brovero, G. Brett Moreau, Anjali Sengar, Crystal M. Richardson, Sayeh Agah, Anna Pomés, Peter M. Kasson, Mark A. Tomai, Christopher B. Fox, William A. Petri |
| 184 |
[GO] |
2021―Nov―04 |
Distinct SARS-CoV-2 antibody reactivity patterns elicited by natural infection and mRNA vaccination |
Rafael Assis, Aarti Jain, Rie Nakajima, Algis Jasinskas, Saahir Khan, Anton Palma, Daniel M. Parker, Anthony Chau, Sina Hosseinian, Milind Vasudev, Connie Au, Kathleen Powers, Paramveer S. Birring, Brandon Chin, Rana Andary, Joshua M. Obiero, Delia Tifrea, Amanda Leung, Christina Grabar, Fjolla Muqolli, Ghali Khalil, Jessica Colin Escobar, Jenny Ventura, D. Huw Davies, Bruce Albala, Bernadette Boden-Albala, Sebastian Schubl, Philip L. Felgner |
| 185 |
[GO] |
2021―Oct―28 |
Scientific rationale for developing potent RBD-based vaccines targeting COVID-19 |
Harry Kleanthous, Judith Maxwell Silverman, Karen W. Makar, In-Kyu Yoon, Nicholas Jackson, David W. Vaughn |
| 186 |
[GO] |
2021―Oct―28 |
A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge |
Kathryn McGuckin Wuertz, Erica K. Barkei, Wei-Hung Chen, Elizabeth J. Martinez, Ines Lakhal-Naouar, Linda L. Jagodzinski, Dominic Paquin-Proulx, Gregory D. Gromowski, Isabella Swafford, Akshaya Ganesh, Ming Dong, Xiankun Zeng, Paul V. Thomas, Rajeshwer S. Sankhala, Agnes Hajduczki, Caroline E. Peterson, Caitlin Kuklis, Sandrine Soman, Lindsay Wieczorek, Michelle Zemil, Alexander Anderson, Janice Darden, Heather Hernandez, Hannah Grove, Vincent Dussupt, Holly Hack, Rafael de la Barrera, Stasya Zarling, James F. Wood, Jeffrey W. Froude, Matthew Gagne, Amy R. Henry, Elham Bayat Mokhtari, Prakriti Mudvari, Shelly J. Krebs, Andrew S. Pekosz, Jeffrey R. Currier, Swagata Kar, Maciel Porto, Adrienne Winn, Kamil Radzyminski, Mark G. Lewis, Sandhya Vasan, Mehul Suthar, Victoria R. Polonis, Gary R. Matyas, Eli A. Boritz, Daniel C. Douek, Robert A. Seder, Sharon P. Daye, Mangala Rao, Sheila A. Peel, M. Gordon Joyce, Diane L. Bolton, Nelson L. Michael, Kayvon Modjarrad |
| 187 |
[GO] |
2021―Oct―25 |
Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in Singapore |
Bei Wang, Yun Shan Goh, Tessa Prince, Eve Zi Xian Ngoh, Siti Nazihah Mohd Salleh, Pei Xiang Hor, Chiew Yee Loh, Siew Wai Fong, Catherine Hartley, Seow-Yen Tan, Barnaby Edward Young, Yee-Sin Leo, David C. Lye, Sebastian Maurer-Stroh, Lisa F. P. Ng, Julian A. Hiscox, Laurent Renia, Cheng-I Wang |
| 188 |
[GO] |
2021―Oct―20 |
An alphavirus replicon-based vaccine expressing a stabilized Spike antigen induces protective immunity and prevents transmission of SARS-CoV-2 between cats |
Martijn A. Langereis, Irina C. Albulescu, Judith Stammen-Vogelzangs, Morindy Lambregts, Ken Stachura, Suzan Miller, Angela M. Bosco-Lauth, Airn E. Hartwig, Stephanie M. Porter, Michelle Allen, Mark Mogler, Frank J. M. van Kuppeveld, Berend-Jan Bosch, Paul Vermeij, Ad de Groof, Richard A. Bowen, Randy Davis, Zach Xu, Ian Tarpey |
| 189 |
[GO] |
2021―Oct―14 |
INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants |
Viviane M. Andrade, Aaron Christensen-Quick, Joseph Agnes, Jared Tur, Charles Reed, Richa Kalia, Idania Marrero, Dustin Elwood, Katherine Schultheis, Mansi Purwar, Emma Reuschel, Trevor McMullan, Patrick Pezzoli, Kim Kraynyak, Albert Sylvester, Mammen P. Mammen, Pablo Tebas, J. Joseph Kim, David B. Weiner, Trevor R. F. Smith, Stephanie J. Ramos, Laurent M. Humeau, Jean D. Boyer, Kate E. Broderick |
| 190 |
[GO] |
2021―Sep―30 |
The shot, the message, and the messenger: COVID-19 vaccine acceptance in Latin America |
Pablo Argote, Elena Barham, Sarah Zukerman Daly, Julian E. Gerez, John Marshall, Oscar Pocasangre |
| 191 |
[GO] |
2021―Aug―24 |
Neutralization of MERS coronavirus through a scalable nanoparticle vaccine |
Mona O. Mohsen, Dominik Rothen, Ina Balke, Byron Martina, Vilija Zeltina, Varghese Inchakalody, Zahra Gharailoo, Gheyath Nasrallah, Said Dermime, Kaspars Tars, Monique Vogel, Andris Zeltins, Martin F. Bachmann |
| 192 |
[GO] |
2021―Aug―16 |
Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action |
Franz X. Heinz, Karin Stiasny |
| 193 |
[GO] |
2021―Aug―12 |
National control laboratory independent lot testing of COVID-19 vaccines: the UK experience |
Nicola J. Rose, Paul Stickings, Silke Schepelmann, Marc J. A. Bailey, Chris Burns |
| 194 |
[GO] |
2021―Aug―11 |
Benefit of COVID-19 vaccination accounting for potential risk compensation |
John P. A. Ioannidis |
| 195 |
[GO] |
2021―Aug―05 |
Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic |
Samir Andrade Mendonça, Reka Lorincz, Paul Boucher, David T. Curiel |
| 196 |
[GO] |
2021―Jul―22 |
A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19 |
Delphine C. Malherbe, Drishya Kurup, Christoph Wirblich, Adam J. Ronk, Chad Mire, Natalia Kuzmina, Noor Shaik, Sivakumar Periasamy, Matthew A. Hyde, Julie M. Williams, Pei-Yong Shi, Matthias J. Schnell, Alexander Bukreyev |
| 197 |
[GO] |
2021―Jun―17 |
A cautionary perspective regarding the isolation and serial propagation of SARS-CoV-2 in Vero cells |
Simon G. P. Funnell, Babak Afrough, John James Baczenas, Neil Berry, Kevin R. Bewley, Rebecca Bradford, Clint Florence, Yann Le Duff, Mark Lewis, Ryan V. Moriarty, Shelby L. O. Connor, Karen L. Osman, Steven Pullan, Sujatha Rashid, Kevin S. Richards, Kimberly J. Stemple, Ivana Knezevic |
| 198 |
[GO] |
2021―May―14 |
Public attitudes toward COVID-19 vaccination: The role of vaccine attributes, incentives, and misinformation |
Sarah Kreps, Nabarun Dasgupta, John S. Brownstein, Yulin Hswen, Douglas L. Kriner |
| 199 |
[GO] |
2021―May―13 |
Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation |
Lauren M. Meyers, Andres H. Gutiérrez, Christine M. Boyle, Frances Terry, Bethany G. McGonnigal, Andres Salazar, Michael F. Princiotta, Wiliam D. Martin, Anne S. De Groot, Leonard Moise |
| 200 |
[GO] |
2021―May―13 |
Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2 |
Ian McDonald, Sam M. Murray, Catherine J. Reynolds, Daniel M. Altmann, Rosemary J. Boyton |
| 201 |
[GO] |
2021―May―10 |
ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets |
Glenn A. Marsh, Alexander J. McAuley, Gough G. Au, Sarah Riddell, Daniel Layton, Nagendrakumar B. Singanallur, Rachel Layton, Jean Payne, Peter A. Durr, Hannah Bender, Jennifer A. Barr, John Bingham, Victoria Boyd, Sheree Brown, Matthew P. Bruce, Kathie Burkett, Teresa Eastwood, Sarah Edwards, Tamara Gough, Kim Halpin, Jenni Harper, Clare Holmes, William S. J. Horman, Petrus Jansen van Vuren, Suzanne Lowther, Kate Maynard, Kristen D. McAuley, Matthew J. Neave, Timothy Poole, Christina Rootes, Brenton Rowe, Elisha Soldani, Vittoria Stevens, Cameron R. Stewart, Willy W. Suen, Mary Tachedjian, Shawn Todd, Lee Trinidad, Duane Walter, Naomi Watson, Trevor W. Drew, Sarah C. Gilbert, Teresa Lambe, S. S. Vasan |
| 202 |
[GO] |
2021―Apr―22 |
Recommendations for acceleration of vaccine development and emergency use filings for COVID-19 leveraging lessons from the novel oral polio vaccine |
Natalie Thiel, Casey Selwyn, Georgina Murphy, Shmona Simpson, Ajoy C. Chakrabarti |
| 203 |
[GO] |
2021―Apr―21 |
Strategy for COVID-19 vaccination in India: the country with the second highest population and number of cases |
Velayudhan Mohan Kumar, Seithikurippu R. Pandi-Perumal, Ilya Trakht, Sadras Panchatcharam Thyagarajan |
| 204 |
[GO] |
2021―Apr―19 |
Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models |
Kirill V. Kalnin, Timothy Plitnik, Michael Kishko, Jinrong Zhang, Donghui Zhang, Adrien Beauvais, Natalie G. Anosova, Tim Tibbitts, Josh DiNapoli, Gregory Ulinski, Peter Piepenhagen, Sheila M. Cummings, Dinesh S. Bangari, Susan Ryan, Po-Wei D. Huang, James Huleatt, Deanne Vincent, Katherine Fries, Shrirang Karve, Rebecca Goldman, Hardip Gopani, Anusha Dias, Khang Tran, Minnie Zacharia, Xiaobo Gu, Lianne Boeglin, Jonathan Abysalh, Jorel Vargas, Angela Beaulieu, Monic Shah, Travis Jeannotte, Kimberly Gillis, Sudha Chivukula, Ron Swearingen, Victoria Landolfi, Tong-Ming Fu, Frank DeRosa, Danilo Casimiro |
| 205 |
[GO] |
2021―Apr―16 |
mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents |
Susanne Rauch, Nicole Roth, Kim Schwendt, Mariola Fotin-Mleczek, Stefan O. Mueller, Benjamin Petsch |
| 206 |
[GO] |
2021―Apr―14 |
Access to and equitable distribution of COVID-19 vaccine in low-income countries |
Krishna Prasad Acharya, Tirth Raj Ghimire, Supram Hosuru Subramanya |
| 207 |
[GO] |
2021―Apr―13 |
Considerations for bioanalytical characterization and batch release of COVID-19 vaccines |
Gautam Sanyal, Anna Särnefält, Arun Kumar |
| 208 |
[GO] |
2021―Mar―30 |
Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19-like disease in hamsters |
Qingmei Jia, Helle Bielefeldt-Ohmann, Rachel M. Maison, Saša Masleša-Galić, Sarah K. Cooper, Richard A. Bowen, Marcus A. Horwitz |
| 209 |
[GO] |
2021―Mar―25 |
The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization |
Jing Zou, Xuping Xie, Camila R. Fontes-Garfias, Kena A. Swanson, Isis Kanevsky, Kristin Tompkins, Mark Cutler, David Cooper, Philip R. Dormitzer, Pei-Yong Shi |
| 210 |
[GO] |
2021―Mar―19 |
Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease |
Joan E. M. van der Lubbe, Sietske K. Rosendahl Huber, Aneesh Vijayan, Liesbeth Dekking, Ella van Huizen, Jessica Vreugdenhil, Ying Choi, Miranda R. M. Baert, Karin Feddes-de Boer, Ana Izquierdo Gil, Marjolein van Heerden, Tim J. Dalebout, Sebenzile K. Myeni, Marjolein Kikkert, Eric J. Snijder, Leon de Waal, Koert J. Stittelaar, Jeroen T. B. M. Tolboom, Jan Serroyen, Leacky Muchene, Leslie van der Fits, Lucy Rutten, Johannes P. M. Langedijk, Dan H. Barouch, Hanneke Schuitemaker, Roland C. Zahn, Frank Wegmann |
| 211 |
[GO] |
2021―Mar―19 |
Human endogenous retrovirus-enveloped baculoviral DNA vaccines against MERS-CoV and SARS-CoV2 |
Hansam Cho, Yuyeon Jang, Ki-Hoon Park, Hanul Choi, Aleksandra Nowakowska, Hee-Jung Lee, Minjee Kim, Min-Hee Kang, Jin-Hoi Kim, Ha Youn Shin, Yu-Kyoung Oh, Young Bong Kim |
| 212 |
[GO] |
2021―Feb―22 |
SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates |
Nikolaos C. Kyriakidis, Andrés López-Cortés, Eduardo Vásconez González, Alejandra Barreto Grimaldos, Esteban Ortiz Prado |
| 213 |
[GO] |
2021―Feb―11 |
Promoting versatile vaccine development for emerging pandemics |
Joshua T. Monrad, Jonas B. Sandbrink, Neil G. Cherian |
| 214 |
[GO] |
2021―Jan―25 |
Protective efficacy of a SARS-CoV-2 DNA vaccine in wild-type and immunosuppressed Syrian hamsters |
Rebecca L. Brocato, Steven A. Kwilas, Robert K. Kim, Xiankun Zeng, Lucia M. Principe, Jeffrey M. Smith, Jay W. Hooper |
| 215 |
[GO] |
2021―Jan―04 |
SARS-CoV-2 structural features may explain limited neutralizing-antibody responses |
Martin F. Bachmann, Mona O. Mohsen, Lisha Zha, Monique Vogel, Daniel E. Speiser |
| 216 |
[GO] |
2020―Nov―03 |
Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infections |
Jay Epstein, W. Martin Smid, Silvano Wendel, Daniel Somuah, Thierry Burnouf |
| 217 |
[GO] |
2020―Oct―23 |
Navigating facilitated regulatory pathways during a disease X pandemic |
Shmona Simpson, Ajoy Chakrabarti, David Robinson, Keith Chirgwin, Murray Lumpkin |
| 218 |
[GO] |
2020―Oct―16 |
Rabies virus-based COVID-19 vaccine CORAVAX™ induces high levels of neutralizing antibodies against SARS-CoV-2 |
Drishya Kurup, Christoph Wirblich, Holly Ramage, Matthias J. Schnell |
| 219 |
[GO] |
2020―Oct―08 |
Experimental and in silico evidence suggests vaccines are unlikely to be affected by D614G mutation in SARS-CoV-2 spike protein |
Alexander J. McAuley, Michael J. Kuiper, Peter A. Durr, Matthew P. Bruce, Jennifer Barr, Shawn Todd, Gough G. Au, Kim Blasdell, Mary Tachedjian, Sue Lowther, Glenn A. Marsh, Sarah Edwards, Timothy Poole, Rachel Layton, Sarah-Jane Riddell, Trevor W. Drew, Julian D. Druce, Trevor R. F. Smith, Kate E. Broderick, S. S. Vasan |
| 220 |
[GO] |
2020―Sep―28 |
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses |
Rinke Bos, Lucy Rutten, Joan E. M. van der Lubbe, Mark J. G. Bakkers, Gijs Hardenberg, Frank Wegmann, David Zuijdgeest, Adriaan H. de Wilde, Annemart Koornneef, Annemiek Verwilligen, Danielle van Manen, Ted Kwaks, Ronald Vogels, Tim J. Dalebout, Sebenzile K. Myeni, Marjolein Kikkert, Eric J. Snijder, Zhenfeng Li, Dan H. Barouch, Jort Vellinga, Johannes P. M. Langedijk, Roland C. Zahn, Jerome Custers, Hanneke Schuitemaker |
| 221 |
[GO] |
2020―Sep―04 |
Impact of glycan cloud on the B-cell epitope prediction of SARS-CoV-2 Spike protein |
René Wintjens, Amanda Makha Bifani, Pablo Bifani |
| 222 |
[GO] |
2020―Jul―27 |
Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19 |
Simon P. Graham, Rebecca K. McLean, Alexandra J. Spencer, Sandra Belij-Rammerstorfer, Daniel Wright, Marta Ulaszewska, Jane C. Edwards, Jack W. P. Hayes, Veronica Martini, Nazia Thakur, Carina Conceicao, Isabelle Dietrich, Holly Shelton, Ryan Waters, Anna Ludi, Ginette Wilsden, Clare Browning, Dagmara Bialy, Sushant Bhat, Phoebe Stevenson-Leggett, Philippa Hollinghurst, Ciaran Gilbride, David Pulido, Katy Moffat, Hannah Sharpe, Elizabeth Allen, Valerie Mioulet, Chris Chiu, Joseph Newman, Amin S. Asfor, Alison Burman, Sylvia Crossley, Jiandong Huo, Raymond J. Owens, Miles Carroll, John A. Hammond, Elma Tchilian, Dalan Bailey, Bryan Charleston, Sarah C. Gilbert, Tobias J. Tuthill, Teresa Lambe |
| 223 |
[GO] |
2020―Jul―06 |
Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic |
Leonardo M. R. Ferreira, Mohammed A. Mostajo-Radji |
| 224 |
[GO] |
2020―Jun―15 |
Applying lessons from the Ebola vaccine experience for SARS-CoV-2 and other epidemic pathogens |
Jayanthi Wolf, Samantha Bruno, Michael Eichberg, Risat Jannat, Sharon Rudo, Susan VanRheenen, Beth-Ann Coller |
| 225 |
[GO] |
2020―May―28 |
Universal coronavirus vaccines: the time to start is now |
Luca T. Giurgea, Alison Han, Matthew J. Memoli |
| 226 |
[GO] |
2020―May―25 |
Certainty of success: three critical parameters in coronavirus vaccine development |
David C. Kaslow |
| 227 |
[GO] |
2020―Apr―30 |
COVID-19 vaccines: breaking record times to first-in-human trials |
Young Chan Kim, Barbara Dema, Arturo Reyes-Sandoval |
| 228 |
[GO] |
2020―Mar―06 |
The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines |
Weilong Shang, Yi Yang, Yifan Rao, Xiancai Rao |
| 229 |
[GO] |
2019―Dec―06 |
Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts |
Raffael Nachbagauer, Bruno Salaun, Daniel Stadlbauer, Mohammad A. Behzadi, Damien Friel, Arvind Rajabhathor, Angela Choi, Randy A. Albrecht, Muriel Debois, Adolfo García-Sastre, Ronan N. Rouxel, Weina Sun, Peter Palese, Corey P. Mallett, Bruce L. Innis, Florian Krammer, Carine Claeys |
|
